In: Telomeres: Function, Shortening and Lengthening
ISBN 978-1-60692-350-4
Editor: Leonardo Mancini, pp.
© 2009 Nova Science Publishers, Inc.
Chapter 2
The Role of Te lom er e- Te lom er a se
Syst em in Age - Re la t ed Fit ne ss D e cline ,
a Ta m e able Pr oce ss
Giacinto Libertini
Independent Researcher,
via Cavour 13, Caivano 80023, Naples, Italy
Azienda Sanitaria Locale NA3, giacinto.libertini@tin.it
Abst r a ct
In our body there is a continuous cell turnover. Every day innumerable cells die by
programmed cell death, in particular apoptosis, and are replaced by others deriving from
stem cells. With the passing of time, this turnover is limited by sophisticated
mechanisms, genetically determined and regulated, which control the telomeretelomerase system and therefore cell duplication capacity (replicative senescence) and
overall functionality (cell senescence).
Alterations of cell turnover mechanisms cause dramatic syndromes, such as
dyskeratosis congenita and Werner syndrome, while the normal age-related slowdown
and stopping of this turnover causes a fitness decline that is defined senescence in its
more advanced expressions. The fitness decline documented in the wild for many species
should not be confused with the mortality increment observed for animals, as
Caenorhabditis elegans and Drosophila melanogaster, in artificial conditions at ages
non-existent in the wild.
Many species are not subject to this fitness decline and, in the case their individuals
reach very old ages in the wild, are defined as ageless animals or species with ‘negligible
senescence’. For some of them, the functionality of the telomere-telomerase system has
been documented as unvaried at older ages.
Indeed, the fitness decline appears not an inevitable decay but a very sophisticated
function, favoured for its greater inclusive fitness in particular selective conditions, and,
being a function, in principle modifiable and governable. This leads to the prospect that
senescence will be tamed in the not too distant future, in particular by control of, or more
audaciously, by a modification of, the genetic determinants of the telomere-telomerase
system. Such a prospect is radically different from the present advances in medical cures
that are only increasing the proportion of disabled ultra-octogenarians.
2
Giacinto Libertini
Be hind t he Sce ne s: I nt r oduct ion
When Darwin proposed the hypothesis of evolution by natural selection, two big
problems undermined the reliability of the great theory.
The first was the existence of insect species with social organisation (bees, ants, etc.). If
natural selection favours individuals with greater fitness and reproductive success, how can
one explain the fact that worker individuals of these species nurse the progeny of queens and
do not procreate themselves? What possible selective mechanisms can favour the genes
determining such odd behaviour? Darwin, the father of modern biology, did not know how to
answer: as an improvised patch for a wonderful new dress with a bad tear, he justified all this
by maintaining that such behaviour was favoured because it was advantageous for the species
[1]. He was wrong, and the correct answer was discovered nearly a century later, as will soon
be discussed.
The second problem was even more serious. For many species, Homo sapiens included,
an increase in chronological age is accompanied by a fitness decline in the wild. That is to
say, mortality rates increase with age in the wild [2,3,4,5,6,7,8,9]. Regarding this fitness
decline, referred to as “aging” in its more advanced expression (a popular and terrible name),
if natural selection favoured the fittest, how was this explicable? Darwin had two alternatives,
both difficult and fraught with implications. The first (nonadaptive hypothesis) demanded the
admission that natural selection was not able to favour genes suited to keeping fitness stable
at increasing ages. However, was it possible that natural selection, which is thought to have
moulded the eye, brain, hand and numberless marvels in numberless animal, plant and
microbe species, failed in the task of keeping fitness stable at greater ages? Moreover, if this
is the case, then why has this hypothetical incapacity of selection been greater for some
species that age quickly and lesser for other species which age slowly or even not at all?
The other possibility (adaptive hypothesis) was that this fitness decline had some
unknown evolutionary advantage. This hypothesis seemed even more arduous: how could an
anticipated death be evolutionarily advantageous? Who could maintain such a thing without
being considered a little muddled, or worse? Darwin could not give an answer to the second
problem, thus it was aptly named Darwin’s dilemma [10].
Some years later, August Weissmann, using extraordinary intuition, tried to give an
answer. Unfortunately, he did not formulate a clear exposition or give solid scientific proofs,
although he did hint that the anticipated death of old individuals was beneficial because this
gave more space to new generations which was useful for the evolution of species [11,12]. In
short, Weissmann was a supporter of the adaptive hypothesis of fitness decline, although he
later disavowed it [12,13]. Furthermore, about the mechanism underlying this decline, he
observed that the cells of the various organs and tissues were renewed continuously and that
when this turnover slackened or stopped, the organs or tissues reduced or lost their
functionality with negative effects on fitness [12].
His adaptive hypothesis was original but not well inferred from a theoretical viewpoint.
Moreover, as common experience testifies, all inanimate things deteriorate with the passing of
time, so why not assume that living beings, too, are subject to the same inexorable law? In
fact, “common sense” seems to strongly suggest that the nonadaptive hypothesis of fitness
decline is correct, even if this requires the admission that natural selection is incapable of
solving this specific problem.
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
3
On the contrary, the cell turnover mechanism hypothesised by Weissmann for the aging
was easier to understand and accept but it had an unhappy fortune, too, at least for the next 70
years. Indeed, an illustrious Nobel prize winner, Alexis Carrel, demonstrated that cells
explanted and cultivated in vitro multiplied an unlimited number of times [14], meaning that
Weissmann’s hypothesis was groundless and unacceptable.
Poor Weissmann with his intuitions seemed to miss every time!
In 1961 an obscure researcher, Leonard Hayflick, cultivated fibroblasts in vitro and
discovered that they multiplied a limited number of times, a finding in clear contrast with
Carrel’s results. After having excluded any factor as a possible cause of such stoppage in cell
duplication, he decided to publish his findings. However, the authoritative journal to which
the paper was submitted rejected it, with the statement that it was a priori unacceptable since
the results were in plain contrast with what had been definitively demonstrated and what was
accepted as scientifically sound. Fortunately, Hayflick was stubborn and succeeded to publish
his paper in a less authoritative journal which was more open to new ideas [15].
Carrel’s observations (likely due to errors in cell culture methodology) were overthrown
and Weissmann’s hypothesis recovered its value! Hayflick stated in 1977 that the limits in
cell duplication (Hayflick limit) were the likely cause of the aging: “... if normal animal cells
do indeed have only a limited capacity for division in cell culture, the manifestations of aging
might very well have an intracellular basis.” [16]. However, this statement was in contrast
with other ideas that by this time were imposing themselves about the aging [17], i.e.:
“mutation accumulation” theory — “Aging” is due to the effects of harmful
mutations, accumulated over evolutionary time, manifesting themselves at older ages
when, in the wild, survivors are few or absent and, consequently, selective forces are too
weak to eliminate them [18,19,20,21,22].
“antagonistic pleiotropy” theory — “Senescence” is caused by pleiotropic genes with
beneficial effects at early ages and deleterious effects at later ages [23,24].
“disposable soma” theory — “Aging” has environmental or somatic and not genetic
causes, and evolutionary responses to them are increasingly limited at older ages by
physiological, biochemical or environmental constraints. Therefore, in the evolutionary
search of an optimal allocation of metabolic resources between somatic maintenance and
reproduction, the second is preferred [25,26].
In a relatively recent paper, Hayflick, as a prophet repudiating himself, did not mention
the pivotal importance of cell duplication limits for the mechanisms of aging and instead
proclaimed: “Ageing is a stochastic process that ... results from the diminishing energy
available to maintain molecular fidelity. This disorder has multiple aetiologies including
damage by reactive oxygen species.” [27]
In the years 1970-76, I was a simple student of medicine, rich in a wide ignorance and in
the foolhardiness of which the ignorant persons enjoy, but —merit among the faults— was
strongly struck by Hayflick’s results that I considered of extreme importance for aging
studies. I became an enthusiast of Hayflick’s discovery and of its implications and remained
firm in this belief even when Hayflick diminished or denied the importance and the
implications of his results.
Stimulated by them, I tried to explain, in precise terms of natural selection, the advantage
of a quicker turnover of generations that seemed to me the automatic consequence of the
4
Giacinto Libertini
Hayflick limit or, in the case that this limit was unimportant, the advantage of the evident
restraints in the individual duration of life for many species, man included, whichever the
mechanism causing those restraints was.
Knowing what Weissmann had hinted at, and stimulated by the suggestions of two
botanists [28,29], I formulated a mathematical model demonstrating with precision how a
quicker generation turnover allowed a quicker diffusion of a favourable gene within a species.
In numerical terms, this study modelled the spreading velocity of a gene within a species: the
increment by x% of gene advantage or the reduction by an equal x% of the mean duration of
individual life had the same effects (Figure 1).
(A)
(B)
Figure 1. (A) Spreading of a gene C according to the variation of the advantage (S) caused by the gene
C, supposing a constant mean duration of life. (B) Spreading of the same gene C according to the
variation of the mean duration of life (ML), supposing a constant value of S (= 0.01) [38,39,40].
This study was essentially the reformulation of Weissmann’s intuition in mathematical
terms. As examples in more comprehensible terms: populations of bacteria or insects under
the action of antibiotics or insecticides become resistant to the action of these substances in
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
5
the space of a certain number of generations. For a bacterium this time could be a few days,
for an insect few years. For a human population, an equivalent evolution would require
centuries as a consequence of the much slower turnover of generations.
However, this argument only pointed out that, all other things being equal, species with a
smaller mean duration of the life (i.e. a quicker generation turnover) are favoured. This study
did not prove that within a species a gene limiting the duration of life would be favoured by
natural selection. Darwin’s argument that this could be favoured in terms of group selection
was untenable [30,31] and Weissmann’s intuition needed something more.
Then, I obtained a likely solution from the extraordinary results of a group of researchers
[32,33,34,35,36], whom in the intervening years had formulated a brilliant solution for the
problem of the evolutionary mechanisms explaining the organisation of the social insects, the
first of the above said great problems undermining the theory of evolution.
Until this time, accepted evolutionary arguments were only in terms of selection
proportionate to the fitness of the single individual (individual fitness). In fact, for a gene
causing an advantage or disadvantage (S) and acting in an individual with the capacity P of
having progeny (reproductive value), the selective force (F) operating in favour or against the
gene was calculated as proportional to the product of S by P:
F∝S⋅P
(1)
In the solution maintained by those researchers, it was pointed out that for a gene existing
and acting in an individual, defined as individual 1, it was necessary to also calculate the
effects of the actions of the same gene on the fitness of other individuals (2, 3, ..., n)
genetically related with the individual 1 (inclusive fitness). Indeed, for each gene C, it was
necessary to calculate the sum of the values of the advantage or disadvantage for each
individual X for which the gene C had a consequence (S x ), multiplied by the reproductive
value of each individual X (P x ), then multiplied by the coefficient of relationship between
individual 1 and individual X (r x , or the probability that gene C is present in X).
Therefore:
F ∝ Σ(S x ⋅P x ⋅r x ) with X from 1 to n
(2)
As a simple and easily comprehensible example, a young mother with the act of nursing
her child reduces her fitness (because she spends energy resources) but the same act is
indispensable for the survival of her child, who has a 50% probability of having the same
genes as his mother. Therefore, the small disadvantage for the mother caused by the nursing
(S 1 = -y, with y having a small value) is clearly exceeded by the great advantage for the child
(S 2 = 1) reduced by 50% (r 2 = 0.5): the inclusive fitness of a gene that determines the nursing
is positive and the gene is favoured by natural selection. In numerical terms, supposing that
the mother is young and her reproductive value is maximum (P 1 = 1) and the child
reproductive value is also high (P 2 >> 0; supposing that only 60% of the children reach the
reproductive age, P 2 ≈ 0.6):
F ∝ S 1 ⋅ P 1 ⋅ r 1 + S 2 ⋅ P 2 ⋅ r 2 = -y ⋅ 1 ⋅ 1 + 1 ⋅ 0.6 ⋅ 0.5 = -y + 0.3 >> 0
(3)
6
Giacinto Libertini
With the simpler formula (1), it is clear that the nursing gene would be eliminated by natural
selection.
Other two examples are illustrated in Figure 2.
It has to be noticed that formula (2) becomes formula (1) in cases where the gene only
has effects for individual 1, because the coefficient of relationship of individual 1 with
himself is clearly 1 (r 1 = 1).
Figure 2. Actions between two brothers (<1> and <2>) that, being brothers, have in common half of the
genes (r = 0.5). (A) “Altruism” - By effect of a gene X, <1> gives something of his resources to <2>,
increasing the fitness of <2>. His fitness is reduced but the fitness of <2> is increased more than the
double of the reduction for <1>: the gene X is favoured by selection. (B) “Egoism” – By effect of a
gene X, <1> subtracts something of the resources of <2>. His fitness is increased but the fitness of <2>
is reduced less than the half of this increase: the gene X is favoured by selection. The picture is from
Wilson, partially redrawn [35].
Following this principle, because for the peculiar genetic mechanism with the difficult
name haplodiploidy (males are haploid, while females are diploid) the coefficient of
relationship between two sister bees is 0.75 while that between a mother bee and its daughter
is 0.5 (see Figure 3-C), the inclusive fitness of a gene determining the nursing of a sister grub
by a worker bee is favoured by natural selection more than a gene determining the nursing of
a daughter grub by its mother bee. This is the same for ants.
With all the details and quibbles that such a scientific formulation involved, inclusive
fitness adequately explained the social organisation of bees and ants. Darwinian theory was
enriched and an unresolved problem was settled!
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
A
7
B
C
Figure 3. (A) A queen ant with some worker ants; (B) A beehive; (C) For ants and bees, females are
diploid while males are haploid. Therefore, a mother gives to a daughter 50% of its genes, while a
father gives 100% of its genes. The probability that a gene is the same in the mother and the daughter,
alias the coefficient of relationship (r) between mother and daughter, is 0.5. Otherwise, r between the
two daughters is 0.75, the arithmetical mean between 50% genes in common with the mother and 100%
in common with the father.
Drawing my inspiration from the same concepts, I realised that a life limiting gene was
certainly harmful for individual where it acted (individual 1), but, considering that the death
of individual 1 gave space for other individuals (2, 3, ... n) and allowed a quicker turnover of
generation and so a quicker evolution for 2, 3, ... n, if those individuals were genetically
related to individual 1, the inclusive fitness of the gene could be positive and in certain
conditions (in short, a population divided in demes and numerically stable, alias K-selection
[37]) the gene would be favoured by evolution.
Wonderful, I had a possible solution for Darwin’s dilemma, the evolutionary key for the
basis of aging!
I had to publish my arguments, but I feared greatly that others could steal my ideas. I
thought they would be easily understood, accepted and therefore exploited by others, but how
wrong I was!
8
Giacinto Libertini
Consequently, I decided that before the publication of my ideas on a scientific journal, for
precaution it was necessary to print a book stating them so that any doubt of first claim would
be cancelled.
Therefore, in 1983 I published in Italian a book where the above said ideas, and others,
were expounded [38]. I sent copies of the book to many personalities of the Italian scientific
world.
Well, the book was a total commercial failure and no one replied (but 21 years later Prof.
Pietro Omodeo, an illustrious father of Italian biology, reminded me of the copy I’d sent to
him and praised it!). However, my purpose was not economic and I diligently began trying to
publish my hypothesis in the form of a scientific paper in an authoritative journal.
The task revealed itself to be very challenging. I had never published a scientific paper,
my knowledge of English was rudimentary and my academic background was non-existent.
Moreover, internet was not yet born and to even obtain a copy of a scientific paper was
difficult for me. It was like trying to climb a Himalayan peak without any experience of
mountaineering, with no training, without the help of sherpas and with inadequate and
insufficient equipping. My only “force”, besides the conviction of the correctness of my
hypothesis, was an ignorance of this inexperience combined with a good strong dose of
stubbornness. About four years were necessary but in the end, after various rejections and
after various modifications and corrections of the paper, I succeeded in publishing my
hypothesis in the Journal of Theoretical Biology (which rejected it two times before the
acceptance!).
To publish my paper, I had to specify that my topic was not on the imprecise concept of
‘aging’ or ‘senescence’, but on the “increasing mortality with increasing chronological age in
the wild” (IMICAW) [39], a concept that has later referred to as “actuarial senescence in the
wild” [8,9]. In effect, in the wild, the age-related fitness decline, which is a reality for many
species, man included, allows only a few individuals to reach that deterioration of all the
functions called old age or “state of senility”, while in protected conditions (captivity,
civilization, etc.) many individuals reach that age (Figure 4).
In the next weeks after publication, I received by post from each part of the world
(Siberia, Bulgaria, South Africa, Alaska, Argentina, USA, France, ... even one from Italy ...)
48 requests of reprints of the paper. I satisfied all the requests and for each of them I asked for
comments, criticisms and suggestions. I was in very high spirits ... but no one replied.
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
9
Figure 4. Curve A: Life table in the wild of a species with a progressive fitness decline; Curve B: life
table of the same species in artificial conditions of lowered mortality; Line C: arbitrarily defined line
marking the beginning of the old age, or “state of senility” (at the time when the reduced fitness in the
wild has become smaller than an arbitrarily established value). The fraction of individuals surpassing
this line is small in the wild and the grade of their functional decay is in the arbitrarily defined range of
the “state of senility”. With artificially lowered mortality this fraction becomes appreciable or even
preponderant [40].
In the meantime, I sent a copy of the paper to an Italian journal of medical popularisation,
along with a note explaining the importance of the topic and my willingness for a short
informative article. At once the journal agreed to my proposal and asked me to send them the
article and my photograph. Unfortunately, a few days later the journal director called me in
person and, being very apologetic, informed me that the article would not be published
because their trusty “experts” did not share my hypothesis. My objection that a popularisation
journal should spread the news and not do a new judgement by referees, was useless: my
hypothesis was too much in contrast with widely diffused and well established ideas.
Moreover, I was quite aware that I had formulated an evolutionary explanation for agerelated fitness decline but had not proposed a physiological mechanism by which this decline
could occur. I guessed that somehow the Hayflick limit was the key, but the topic was
muddled for me and I did not dare to hazard hypotheses.
I thought that the time was not yet right and decided I should neglect any study on the
topic for about fifteen years. And so I did, devoting my attention to various other things,
things for which a mention here is inappropriate. Only every now and then did I turn my
attention to what had once been my obsession for so long.
In 2000, reading in Nature an “authoritative” paper on aging [17], I noticed the mention,
as proof of the current gerontological theories, of a paper whose title proclaimed:
“Evolutionary Theories of Aging: Confirmation of a Fundamental Prediction, with
Implications for the Genetic Basis and Evolution of Life Span” [9]. At once I looked for a
copy of the article and then realised with astonishment that the statement of the title was in
utter contrast with the results exposed in the text and with the evaluations and conclusions of
10
Giacinto Libertini
the same Author! In fact, Ricklefs who was studying the life tables of many mammal and bird
species in the wild, had found that the reduction of life span caused by the progressive
increment of mortality (“proportion of senescent deaths” in his terminology) was inversely
related to the environmental, or extrinsic, mortality (Figure 5). He declared openly that this
finding was in plain contrast with the predictions of current gerontological theories! However,
in my theory I had predicted that what Ricklefs termed ‘the proportion of senescent deaths’
should be inversely related to the extrinsic mortality - precisely as was documented by him. In
my paper, I had given this paradoxical phenomenon the suggestive name “Methuselah effect”
[39], but I had no empirical proofs of this prediction. Well, ten years after the publication of
my paper, an authoritative scholar, whilst attempting to confirm predictions of the traditional
theories, on the contrary found a clear proof in contrast with them and in support of my
hypothesis! But, why was the contrary conclusion proclaimed in the title? I do not know, but I
fear that with a title conforming to the facts and conclusions exposed in the text, the paper
would have suffered many difficulties in being accepted.
However, I decided that the time was now mature for a renewed attention by myself to
the topic of age-related fitness decline in the wild, and to his human terrible outcome in its
amplified expression at older ages in protected conditions, namely the senile state.
In the following months and years, I sought for and carefully consulted many papers and
books regarding subjects such as telomeres, telomerase, replicative senescence, cell
senescence, apoptosis, cell turnover, and diseases caused by cell turnover disorders, which I
considered as deeply linked to what I investigated.
I looked for and obtained many internet contacts with scholars of various disciplines.
I wrote to Hayflick too, proclaiming my deep-rooted admiration for his essential
discovery and with respectful boldness I asked for his copartnership to what I was
elaborating. Hayflick replied with kindness that he did not share my opinions and that for him
aging was the consequence of a large set of cell alterations well documented by innumerable
experiments. With pride and dismay I perceived that I had become the standard bearer of the
implications of Hayflick’s discovery - in contrast and beyond the position of the same
Hayflick! An enormous weight on weak shoulders, but I was not discouraged ...
Many scholars replied to my requests, some with simple encouragements, and others with
useful criticisms or suggestions. In some cases, the lack of sound objections or criticisms was
an indirect confirmation of the arguments that I was proposing. However, I must express a
particular gratefulness to Jerry Shay, for his useful suggestions on telomeres and telomerase,
a topic in which he is an undisputed master; to Eric Le Bourg, Josh Mitteldorf and Theodore
Goldsmith for their useful mentions of important papers; to Richard Ricklefs for his attention
and kindness. In particular, I am profoundly grateful to Leonard Hayflick for his appreciation
of my last paper (2008), which I have accepted as a sort of scientific blessing.
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
11
A
B
Figure 5. Ricklefs’ observation. (A) Life table in the wild of a species with an age-related increasing
mortality, determined by extrinsic mortality (m 0 ) plus intrinsic mortality (m i ) (Curve 1, continuous
line); hypothetical life tables with the action of m 0 only (Curve 2, dashed line); V is the area delimited
by Curve 1; Z is the area between Curves 1 and 2, alias the “proportion of senescent deaths” (P s ). (B)
Inverse significant correlation between m 0 and the proportion of deaths due to m i (P s ), or ratio Z/(Z+V).
Data are from Ricklefs [9], Table 2 (p. 30). Ricklefs’ Figure 7 (p. 34) has been redrawn. Ordinates are
in logarithmic scale. Open symbols refer to mammal species, solid symbols to bird species.
After some years of study and some useful rejections by qualified journals, in 2006 I
published a paper [40] in which my hypothesis was reaffirmed and an overall interpretation of
aging, both in terms of evolutionary mechanisms and in terms of underlying physiological
mechanisms, was given. Moreover, I clearly expressed the differences between the current
ideas about aging and the new proposed paradigm.
In the next months I wrote a further paper, published in February 2008 [41], where the
strong empirical evidence in support of the adaptive interpretation of age-related fitness
12
Giacinto Libertini
decline in the wild (in different ways formulated by various authors [10,11,39,40,42,43,44])
and against nonadaptive hypothesis [18,19,20,21,22,23,24,25,26] and historical hypothesis
[45] was given.
In the same article, I maintained that experiments about the modifications of life tables of
animals such as Caenorhabditis elegans and Drosophila melanogaster were of little
importance for the study of aging in species such as ours. The reason for this was because C.
elegans and D. melanogaster reach ages in the laboratory that are non-existent in the wild,
thus the studies are observing laboratory artefacts. Furthermore, these animals have no cell
turnover, whereas our species do.
The following exposition is a description of how facts well documented by empirical
evidence and supported by plausible arguments indicate the mechanisms underlying agerelated fitness decline and aging, as I have described in the above said papers, but with further
evidence, details and deductions.
Please, a bit of attention, the explanation of an upsetting drama involving emotionally
and physically all of us begins!
The Pr ot a gonist : Te lom e re - Te lom e r a se Syst e m
Hayflick demonstrated that cultivated human diploid fibroblast-like cells (HDF) from a
variety of normal tissues have a finite growth potential in vitro, i.e. divide only a finite
number of times (“Hayflick limit”) [46,47].
Moreover, it was shown that foetal HDF display a consistently greater number of
population doublings (approximately 50) than cells derived from adult tissues (20-30
doublings) [46]. Growth potential of skin HDF from donors of different ages showed a
reduction of potential doublings of 0.2 doubling per year of life [48]. A decline in growth
potential was reported for epidermal keratinocyte culture [49], arterial smooth-muscle cell
[50] and lens epithelial cell [51]. A positive relationship between growth potential of HDF
cultures and the maximum life span of the species from which the cells are derived was
reported [52].
In 1976, the Hayflick limit was documented in vivo too [53].
In 1975, the unknown mechanism limiting the number of duplication was shown to be in
the nucleus [54].
However, it was known from 1972 that DNA polymerase could not replicate a whole
molecule of DNA and a little part of an end of the molecule would be unreplicated at each
duplication [55]. In the same years, Olovnikov hypothesised that the shortening of DNA
molecule at each duplication after a certain number of times could block cell replication
capacity and that this could explain the Hayflick limit [56].
In 1978, the end of the DNA molecule, defined telomere, which at each cell replication
shortens [57], was shown in a protozoan species to be a simple sequence of nucleotides,
TTGGGG, repeated many times [58]. Later, for mammals, man included, the repeated
sequence was demonstrated to be only a little different (TTAGGG) [59] but common to slime
molds, trypanosomes, and other vertebrates and organisms [60]. Its evolutionary
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
13
conservation, shared even between mammals and unicellular animals, certainly indicated that
the structure has great importance.
However, if the Hayflick limit originated from telomere shortening at each replication, an
explanation for cells with numberless replications, such as germ line cells, was needed. The
discovery of the enzyme telomerase that elongates telomeres was the solution [61], and was
confirmed by its presence in immortal human cell lines [62].
This enzyme was shown to be repressed by regulatory proteins [63]. Moreover,
telomerase deactivation caused telomere shortening and a reduction of growth potential [64].
Conversely, telomerase activation caused telomere lengthening and cell immortalization
[65,66,67,68,69].
Graduality of duplication blockage in a cell population. The simple description that cells
with activated telomerase have an unlimited duplication capacity, while cells with inactivated
telomerase show a limited duplication capacity strictly proportional to telomere length, was
imperfectly supported by empirical data and a more sophisticated and realistic model was
suggested in a review by Blackburn [70]. Indeed, if somatic cell growth potential is strictly
proportional to telomere length, it would be totally unimpaired up to a critical length, while
under this length, namely starting from a certain number of replications, there would be a
sudden slump of the growth potential. However, cell populations show a progressive
reduction of growth potential starting from early ages, that is, for single cells, even with
telomeres having the maximum length, the passage from “cycling state” (duplication
possible) to “noncycling state” (duplication impossible) is stochastic [71,72]. In the aforesaid
review it was suggested (“Blackburn’s hypothesis”) that telomere can switch stochastically
between two states: capped with particular protective nucleoproteins and uncapped. Capping
preserves telomere physical integrity, allowing cell division to proceed. Uncapping occurs
normally in dividing cells, regardless of telomere length, but the probability of returning to
the capped state is proportional to telomere length and the uncapped state, if left uncorrected
too long, elicits the passage to the noncycling state (Figure 6).
Imperfect relation between telomere length and Hayflick limit. To contrast the possible
objection that species, such as the mouse and hamster, with long telomeres [73] age
precociously, it is necessary to point out that Blackburn’s hypothesis does not require, for
different species, a fixed ratio between telomere length and the stability of the telomerecapping nucleoproteins complex. It is easily assumable that the stability of the complex and,
more generally, the modulation of telomere-telomerase function is different for each species
[74].
However, according to this model, and with the support of the aforesaid observations, a
cell population with inactivated telomerase and with telomeres initially at their maximum
length, shows, from the beginning, a gradual reduction of duplication capacity. This gradual
reduction of duplication capacity is at first minimal, but later increases. Besides, even cells
with telomerase activated and therefore telomeres always at maximum length, should show a
small percentage of cells passing to the noncycling state at each division. Stem cells, unlike
germ cells, have levels of telomerase activity that are only partially able to stabilize telomere
length [75] and, therefore, in vivo could not indefinitely replace the differentiated elements in
cell populations that are in renewal [74].
14
Giacinto Libertini
Figure 6. Telomere switches between capped and uncapped states. The probability of being in the
uncapped state increases with telomere shortening at each duplication. In the uncapped state, the
telomere is seen as a broken end and this can cause an end-to-end joining that stops cell duplication
capacity.
Cell senescence. In correlation with the progressive shortening of telomeric DNA, the
expression of many genes, among those usually expressed in the cell, becomes impaired,
jeopardizing overall cell functionality and, consequently, the functions of extracellular matrix
and of other near or physiologically interdependent cells. It has been extensively and soundly
documented that this decay of cell functions (cell senescence) and the progressive reduction
of cell duplication capacities (replicative senescence), somehow depends on the relative
shortening of telomeric DNA (Fossel’s “cell senescence limited model”) [74].
About the mechanism of this gradual alteration of gene expression: “One model of
telomere-gene expression linkage is an altered chromosomal structure (Ferguson et al., 1991),
such as a heterochromatin ‘hood’ that covers the telomere and a variable length of the
subtelomeric chromosome (Fossel, 1996; Villeponteau, 1997; Wright et al., 1999). As the
telomere shortens, the hood slides further down the chromosome (the heterochromatin hood
remains invariant in size and simply moves with the shortening terminus) or the hood
shortens (as the telomere is less capable of retaining heterochromatin). In either case, the
result is an alteration of transcription from portions of the chromosome immediately adjacent
to the telomeric complex, usually causing transcriptional silencing, although the control is
doubtless more complex than merely telomere effect through propinquity (Aparicio and
Gottschling, 1994; Singer et al., 1998; Stevenson and Gottschling, 1999). These silenced
genes may in turn modulate other, more distant genes (or set of genes). There is some direct
evidence for such modulation in the subtelomere ...” [74] (Figure 7).
It is likely that the proteinic “hood” and the “capping nucleoproteins” are the same thing
because: 1) they act in the same part of the chromosome; 2) telomerase activation causes both
telomere lengthening with cell immortalization and the full reversal of cell senescence
manifestations [65,66,69].
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
15
Figure 7. With telomere progressive shortening the expression of many genes results to be impaired. It
is likely that near to telomere there is a tract of DNA regulating overall cell functionality and that with
telomere shortening the proteinic “hood” alters this regulation [74].
The arrangement and action of subtelomeric DNA, which is of great importance for cell
overall functionality, is directly jeopardized by telomere shortening due to its position. This
would be evolutionarily illogical and inexplicable if the hypothesis that this “illogicality”
contributes to mechanisms favoured by natural selection for determining age-related fitness
decay is not accepted.
The reset of telomere clock. Successful fertilization, both in reproduction and in cloned
animals, requires the resetting of “telomere clock” [74]. In other words, cells must somehow
establish the initial length of the telomeric sequence, since each subsequent shortening of this
length will increase the probability of replicative senescence and cell senescence. With a
particular mechanism, which is imaginable (Figure 8), a telomere regulates its future
functionality without the conditioning of its initial length, whose value is “largely irrelevant”
[74]: two Mus strains, one with long (20 kb) telomeres and the other with short (10 kb)
telomeres have equal life spans and similar progressive alterations in gene expression
patterns. The same is true for donor animals and cloned animals that are derived from cells
with reduced telomeres [74].
The case of knockout mice. In comparison to humans, mice and other animals have a
shorter life span but much longer telomeres [73] and a baseline telomerase activity in most
somatic cells [76]. Moreover, in mice with telomerase genetically inactivated (knockout or
mTR-/- mice) four [77] to six [78] generations are necessary before the viability and fertility
is jeopardized, although dysfunctions in organs with highly proliferative cells are shown in
early generations [77,79]. This apparently paradoxical phenomenon is easily explainable with
the model illustrated in Figure 8, as expounded in Figure 9.
16
Giacinto Libertini
Figure 8. In the resetting of the “telomere clock”, the absolute length of the telomere is “largely
irrelevant” [74]. During the resetting phase, the length of the proteinic hood could be shaped
proportionate to telomere length and remain fixed for all the cell life. If subtelomeric DNA regulates
both overall cell functionality (cell senescence) and telomere capped / uncapped state equilibrium
(replicative senescence), this could explain the large irrelevance of the initial telomere length for the
consequences of its subsequent shortenings. According to this model, the probabilities of replicative
senescence and the gradualness of cell senescence after each duplication is proportional to the
progressive blockage of subtelomeric DNA and in function of a prearranged pattern, typical of the
species and of the cell.
Figure 9. According to the model of Figure 8, in knockout mice, the length of proteinic hood, shaped in
the reset phase, is proportionate to telomere length so that telomere functionality is largely irrelevant of
its length. The short life span of mice is explained by a low pattern of telomere + proteinic hood
complex stability.
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
17
With these specifications, the telomere-telomerase system appears to be a highly
sophisticated mechanism, genetically determined and regulated, with pivotal importance for
cell duplication capacities.
Here, we have a protagonist (telomere-telomerase system). However, we need to know
the other protagonist (programmed cell death), the main action (cell turnover), and their cues
for the human scene.
The Ot he r Pr ot a gonist : Pr ogr a m m e d Ce ll D e a t h
A cell may dies by necrosis because of an accidental event (injury, mechanical stress,
infection, ischemia, etc.), or by a form of “programmed cell death” (PCD). The keratinization
of an epidermis or hair cell is a form of PCD. Apoptosis is a peculiar form of PCD with an
ordinate process of self-destruction with non-damaging disposal of cellular debris that makes
it different from necrosis (see Table I). The phenomenon was for the first time described and
clearly differentiated from necrosis in the observation of normal liver epatocytes [80] (Figure
10). However, apoptosis is phylogenetically very ancient and is a characteristic of unicellular
eukaryote species such as Saccharomyces cerevisiae [81, 82].
Selective and programmed cell death by apoptosis is an integral part of multicellular
organ development and an important element in lymphocyte interactions and in many
pathologic mechanisms. A pivotal function of apoptosis in vertebrates is related to cell
turnover in healthy adult organs [83,84,85], as documented for many tissues and organs (i.e.,
biliary epithelial cells [86]; gliocytes [71]; kidneys [87]; pancreatic β-cells [88]; liver [89];
thyroid [90]; lungs (type II alveolar epithelial cells) [91]; cartilage [92]; prostate [93];
adipocytes [94]; bone [95]; skeletal muscle [96,97]).
Table I. Some differences between necrosis and apoptosis
Necrosis
Pathologic process caused by nonphysiological disturbances (e.g., external
injuries, inflammatory factors, lytic viruses,
hypothermia, hypoxia, etc.)
Passive process with no energy requirement
Swelling of organelles and of the whole
cell; mottled chromatin condensation;
random DNA fragmentation
Loss of membrane integrity with release of
cell’s content
In the end, total cell lysis; the organelles are
not functional
Significant inflammatory response
Apoptosis
Physiologic and tightly regulated process
involving activation (e.g., by caspase) and
enzymatic steps
Active process energy dependent
Condensation of cell, organelles and
chromatin; non-random DNA fragmentation
Membrane blebbing without loss of integrity
Cell falls apart into apoptotic bodies bounded
by membranes; the organelles are still
functional
No inflammatory response
18
Giacinto Libertini
Figure 10. Diagram of apoptosis from the original paper of Kerr et al. [80].
The M a in Sce ne : Ce ll Tur nove r
“Each day, approximately 50 to 70 billion cells perish in the average adult because of
programmed cell death (PCD).
Cell death in self-renewing tissues, such as the skin, gut, and bone marrow, is necessary
to make room for the billions of new cells produced daily. So massive is the flux of cells
through our bodies that, in a typical year, each of us will produce and, in parallel, eradicate, a
mass of cells equal to almost our entire body weight” [98] (Figure 11).
For many tissues, cell elimination is completed with the removal by macrophages (red
cell) or with the detaching from the somatic surface (skin, gut), but for many other tissues and
organs, often considered permanent in their cell number, there is a continuous loss of cells by
apoptosis. Just in an organ, the liver, apparently stable as cell composition, in an healthy adult
subject, apoptosis was described for the first time [80].
The continuous death of cells by PCD is balanced by an equal proliferation of appropriate
stem cells, which is regulated and limited by telomere-telomerase system.
Cell turnover is a general pattern in vertebrates, but not for all animals (e.g., the adult
stage of the worm Caenorhabditis elegans has a fixed number of cells).
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
19
Figure 11. A multitude of cells is killed every day by apoptosis. A Colleague commented that this is as:
The Slaughter of the Innocents (painting by Beato Angelico).
In short, at least for vertebrates, three categories of cells are currently distinguished:
1. Those with high turnover: e.g., intestinal crypts cells [99];
2. Those with moderate turnover: e.g., cells of the deep layers of skin and endothelial
cells [100], heart myocytes (“It remains a general belief that the number of myocytes
in the heart is defined at birth and these cells persist throughout life ... But myocytes
do not live indefinitely – they have a limited lifespan in humans and rodents. Cell
loss and myocyte proliferation are part and parcel of normal homeostasis ... The old
heart is characterized by a reduction in cell number and hypertrophy of the remaining
myocytes, and this phenotype has been used to argue against the formation of new
myocytes. But without cell regeneration the rates of cell death would imply that all
myocytes would die during the first few months of a rodent's lifespan. For example,
the left ventricle of a young rat contains 13 x 106 myocytes, and at any point in time
200 and 93,000 myocytes are dying by apoptosis and necrosis, respectively. Because
apoptosis is completed in nearly 4 h and necrosis in roughly 24 h, 94,200 myocytes
are lost in one day. Thus, 2.83 x 106 cells would die in 1 month, and the total 13 x
106 ventricular myocytes would disappear in 5 months.” [101]), muscle myocytes
(Stem cells from muscles of old rodents divide in culture less than cells from muscles
of young rodents [102]; a transplanted muscle suffers ischaemia and complete
degeneration and then there is a complete regeneration by action of host myocyte
stem cells that is poorer in older animals [103]; there is evidence that apoptosis is a
feature in skeletal muscle fibers in several disease like chronic heart failure or
20
Giacinto Libertini
Duchenne muscular dystrophy [104], that reach their deadly end when the replicative
capacity of myocyte stem cells is exhausted.
3. Those with no turnover, e.g., neurones, with few possible exceptions [105] but which
always have metabolic dependence on gliocytes that are cells with turnover [74].
Atrophic syndrome. In correlation with a significant relative shortening of telomeric
DNA, according to Fossel’s “cell senescence limited model” [74], a tissue or an organ should
show an “atrophic syndrome” with the following features:
a.
b.
c.
d.
e.
f.
g.
reduced cell duplication capacity (replicative senescence);
reduced number of cells (atrophy);
slackened cell turnover;
possible substitution of missing specific cells with nonspecific cells;
hypertrophy of the remaining specific cells;
altered functions of cells with shortened telomeres or definitively in noncycling state
(cell senescence);
vulnerability to cancer because of dysfunctional telomere-induced instability [106].
A scheme for cell turnover. Cell turnover may be summarized as follows, (though
obviously the modulation of this turnover will vary according to the cell type) (Figure 12):
−
−
−
Stem cells with active telomerase divide themselves and originate somatic cells with
replication capacity but with telomerase inactivated;
Somatic cells with replication capacity but with telomerase inactivated originate
differentiated somatic cells with no replication capacity and, after a variable number
of duplications and showing a progressive overall function decay (cell senescence),
pass from the cycling state to the non-cycling state;
Somatic cell in non-cycling state (replicative senescence) with increasing cell
senescence.
Figure 12. Stem cells with active telomerase divide themselves and originate somatic cells with
replicative capacity but with telomerase inactivated. Somatic cells in non-cycling state are originated
from these. Replicative senescence and cell senescence contribute to fitness decline that in its more
evident expression becomes the senile state.
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
21
Tw o W r ong Pe rfor m a nce s:
D ysk e r a t osis Conge nit a a nd W e r ne r Syndr om e
The “atrophic syndrome” with dysfunction of stem cells in the cycling state or of somatic
cells in the cycling state should be observable in cells with high and moderate turnover rate,
respectively, while in the old age, alias “state of senility” [23], it should be observable in all
cells and tissues.
In fact, dyskeratosis congenita, an inherited human disease [107], is an excellent model of
the dysfunction of stem cells in the cycling state [100]. Similarly, Werner syndrome is a
prototype of the dysfunction of somatic cells in the cycling state, as illustrated in a review
[108]. The crucial differences between the two syndromes have been skilfully outlined [100].
Dyskeratosis congenita. An autosomal dominant form of dyskeratosis congenita (DC) is
caused by mutations in the gene encoding the RNA part of telomerase [109], while with the
X-linked form of the disease, levels of telomerase are low and telomeres are shorter than
normal [110]. “Problems tend to occur in tissues in which cells multiply rapidly – skin, nails,
hair, gut and bone marrow – with death usually occurring as a result of bone-marrow failure.”
[100]
Defects in DC are present in tissues that have high rates of cell turnover, including those
of the blood system and the intestinal crypts, where telomerase activity has been detected
[100]:
DC patients also suffer from a higher rate of cancer that can likewise be explained by the
lack of telomerase, which results in unstable chromosomes [69,112].
“By contrast, some tissues that have the capacity for cellular replacement, but do not
undergo continuous cell turnover, do not express telomerase in their progenitors. It is these
tissues – such as the deep layers of the skin or the lining of the blood vessels – that might be
expected to suffer most from age-associated telomere depletion, as they have no ability to
regenerate telomeres.
Table II. Alterations in dyskeratosis congenital
Organ
Hair
Oral cavity
Skin
Lungs
Liver
Intestine
Testes
Bone marrow
Cells expressing telomerase
Hair follicle
Squamous epithelium
Basal layer of epidermis
Type 2 alveolar epithelial cells
?
Intestinal crypts
Spermatogonia
Progenitor stem cells
Defect in dyskeratosis congenita
Alopecia
Leukoplakia
Abnormal pigmentation, nail dystrophy
Fibrosis
Cirrhosis
Gut disorders
Hypogonadism
Failure to produce blood cells
These tissues would also be greatly affected by defects in other pathways that maintain
telomeres, such as DNA-recombination processes. This might explain why Werner syndrome,
in which an enzyme involved in DNA processing is affected, yields a closer version of normal
(if premature) ageing than does dyskeratosis congenita. In people with dyskeratosis congenita
22
Giacinto Libertini
and in telomerase-deficient mice, it is tissues that normally express telomerase that one would
predict to suffer most from its loss, and this proves to be the case.” [100]
Werner syndrome (Figure 13). This disease is due to the dysfunction of a member of the
RecQ family of helicases [113] causing a dysfunction of somatic cells in the cycling state. In
this syndrome, cells show high somatic mutation rates, particularly deletions [114], and a
limited replication capacity [48].
Figure 13. A case of Werner syndrome.
Werner syndrome patients show no 'catch-up' growth and a reduced stature, premature
greying and thinning of hair, atrophy of skin, regional atrophy of subcutaneous tissue, voice
changes (weak, high-pitched), diminished fertility (from the third decade), premature
testicular atrophy (from middle age), probably an accelerated loss of primordial ovarian
follicles, cataract (from the beginning of the fourth decade), ulcerations around the Achilles'
tendons and malleoli, osteoporosis, type 2 diabetes mellitus, a variety of benign and
malignant neoplasms, arteriosclerosis, arteriolosclerosis and atherosclerosis, skeletal muscle
atrophy, and death usually for myocardial infarction or for cancer [108], but “... no
convincing evidence of premature senescence in the central nervous system (CNS)” [108].
The ratio of sarcomas to carcinomas is around 1:1, compared with 1:10 in the general ageing
population [115], with origins largely from mesenchymal cells plus some other organ as
thyroid, at least in Japanese subjects [108]. Moreover, “... the distribution of the osteoporosis
is unusual; the long bones of the lower limbs can be more severely affected than those of the
vertebral column. Other unusual radiological features include a characteristic osteosclerosis
of the distal phalanges and subcutaneous calcification of the soft tissues. The ulcerations
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
23
mentioned above are also unusual and can involve the skin around the elbows as well as the
ankles.” [108]
All these characteristics may be interpreted as an atrophic syndrome for non-high
turnover cells, in consequence of the abnormality in DNA metabolism [108]. In particular: 1)
although the crystalline lens has no cell in its core, its functionality depends on lens epithelial
cells that show turnover [51]. “Many investigators have emphasized post-translational
alterations of long-lived crystalline proteins as the basis for senescent ocular cataracts. It is
apparent in Werner syndrome that the cataracts result from alterations in the lens epithelial
cells” [108], which is consistent with age-related reduction in growth potential for lens
epithelial cell reported for normal human subjects [51]; 2) “Of most interest, however, is the
coupling of an abnormality in a RecQ helicase to severe atherosclerosis. In analogy with the
skin ulcers seen in Werner subjects, perhaps normal Werner helicase function is required for
the efficient repair of the haemodinamic shear stress of arteries. Such repair could be at the
level of endothelial cell replication” [108] as suggested for non-Werner subjects [116,117]; 3)
Vulnerability to cancer may be explained by telomere shortness and the consequent unstable
chromosomes [69,111] and this effect should be manifest for non-high turnover cells such as
those of mesenchymal origins and other cells such as those of thyroid; 4) The peculiarities of
osteoporosis and ulcerations, osteosclerosis of distal phalanges, subcutaneous calcification of
the soft tissues, discontinuities of subcutaneous atrophy may “... reflect an unusual response
to repeated, mild local trauma” [108], namely an altered repair capacity due to insufficient
duplication capacity of the necessary repair cells; 5) CNS lesions may be secondary to
vascular pathology [108] but could be a consequence of neuroglia atrophy [74]; 6) “Skeletal
muscle atrophy is at least in part due to disuse, but a primary involvement of that tissue
cannot yet be ruled out.” [108]; 7) type 2 diabetes mellitus might be a consequence of β-cell
atrophy, as for the same type of diabetes in non-Werner subjects an imbalance between β-cell
apoptosis and regeneration rates has been suggested [118,119].
In short, dyskeratosis congenita and Werner syndrome are two model cases of segmental
progeria, that is the altered functionality of only a part of cell phenotypes [74]. For example,
in Werner syndrome there is no association with Alzheimer disease, commonly observed in
the elders. It is plausible that a non-segmental progeria is utterly incompatible with life.
The M a in Act ion: Aging in M a n
A simple spontaneous hypothesis about the mechanisms underlying pathophysiological
alterations in old vertebrate individuals, namely about “damage resulting from intrinsic living
processes” [120] alias “age changes” [27] alias phenomena that are “universal in the species,
degenerative, progressive and intrinsic” [121], has been inferred: the more or less precocious
aging is the consequence of the less or greater genetically determined cell replication capacity
and of the related cell senescence (Fossel’s “cell senescence general model of aging” [74]).
Many experimental data support this hypothesis (e.g., for mice, the p53 tumour
suppressor, activated by numerous stressors, induces apoptosis and cell cycle arrest, causing
reduced longevity, osteoporosis, generalised organ atrophy and a diminished stress tolerance
[122]).
24
Giacinto Libertini
Limiting the argument to the human species because of the large quantity of available
data here, if the hypothesis is true, very old individuals, that is those demonstrating “age
changes” in their most extreme form - excluding “age-associated diseases” and damages by
extrinsic factors (categories 2 and 3, respectively, in Masoro’s 1998 classification [120]) -,
should show widespread and pronounced signs of atrophic syndrome for all organs and
tissues.
Therefore, we will disregard alterations caused by age-related diseases and, as a matter of
prudence, data referred to organs for which hormonal actions are relevant and such as to
confuse their analysis (endocrine glands, genital organs, etc.).
Endot helium
The correct functionality of endothelial cells is essential to avoid atherogenesis and its
complications, such as cardiac infarctions, cerebral ischemia and other diseases derived from
compromised blood circulation [117].
The turnover of these important cells is assured by endothelial progenitor cells, derived
from bone marrow, whose number has been shown to be inversely related to age, reduced by
cardiovascular risk factors (cigarette smoking, diabetes, hypertension, hypercholesteremia,
etc.), and increased by drugs, such as statins, which protect organ integrity [117]. Moreover,
with negative relation, the number of endothelial progenitor cells is a predictor of
cardiovascular risk equal to or more significant than Framingham risk score [117,123].
In the senile state, diseases deriving from a compromised endothelial function increase
exponentially in correlation with the age, even if other cardiovascular risk factors are absent
[124]. These factors anticipate and amplify the risk [124], while drugs with organ protection
qualities, as statins [125], ACE-inhibitors and sartans [126] counter their effects.
Skin
“Stratum corneal thickness is unchanged in the elderly although its moisture content and
cohesiveness are reduced coupled with an increase in renewal time of damaged stratum
corneum. ... Human epidermis is highly proliferative but in a steady-state condition
dependent, as are other self-renewing structures, on slowly cycling, undifferentiated stem
cells. These stem cells are located within the basal compartment of the epidermis – the
nonserrated keratinocytes at the tips of the epidermal rete ridges. Loss of rete ridges and
consequent flattening of the dermal-epidermal junction is a hallmark of intrinsically aged
skin. Such flattening results in a reduction in mean surface area of the dermal-epidermal
junction. One study has estimated a reduction in mean area of dermal-epidermal
junction/mm2 from 2.6 at age 21 to 40 years to 1.9 at age 61 to 80 years. These changes are
accompanied by a reduction in microvilli – cytoplasmic projections from basal keratinocytes
into the dermis. ... The rate of epidermal renewal is reduced in the skin of individuals aged 60
years or greater. ... Melanocytes are decreased in number in intrinsically aged epidermis,
although the estimates of this decrease vary from study to study according to the
methodologies used to quantitate melanocyte numbers. This said, the reduction is in the order
of 8 to 20 percent per decade compared to young adult skin. ... The number of Langerhans
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
25
cells is reduced in intrinsically aged epidermis, ... Gilchrest et al. demonstrated that subjects
aged 62 to 86 years had a 42 percent reduction in the number of Langerhans cells in sunprotected skin as compared to young subjects aged 22 to 26 years. ... Numbers of dermal
fibroblasts decrease with age ... Aged skin is relatively hypovascular, particularly due to loss
of small capillaries that run perpendicular to the dermal-epidermal junction and form capillary
loops. This loss is concomitant with the loss of epidermal rete ridges. Blood vessels within the
reticular dermis are reduced in number and their walls are thinned. ... There is an approximate
50 percent reduction in numbers of mast cells in intrinsically aged skin. ... Eccrine glands are
reduced in number and function in aged skin. ... Age probably reduces and disorganizes the
nerve supply of the skin; indeed there is an approximate two-thirds reduction in numbers of
Pacinian and Meissner's corpuscles with age. ... Hair, particularly scalp hair, is lost with age
in both sexes. ... Nails grow more slowly in the elderly ... The study of aging skin particularly
as a consequence of the ready accessibility of cutaneous tissue is one that presents a paradigm
for aging of other organs.” [127]
Eyes
“Atrophy of the fascial planes within the eyelids may lead to herniation of the orbital fat
into the lid tissue, producing the 'bags under the eyes' frequently seen in the elderly. Atrophy
or disinsertion of the aponeurosis of the levator palpebrae muscle, which ordinarily supports
the upper eyelid, may cause the opened lid to fail to uncover the pupil, as seen in senile
ptosis, despite normal levator muscle function ... Secretory function of the lacrimal glands
declines with age ...” [128]
For crystalline lens and photoreceptor cells, see in the next paragraph.
Orofacial Tissues and Organs
“Structural changes in human oral epithelia with aging include thinning of the epithelial
cell layers (e. g., thinning of the lingual epithelial,) diminished keratinization, and
simplification of epithelial structure. ... Histologic studies of aging salivary glands show a
gradual loss of acinar elements, a relative increase in the proportion of ductal elements, an
increase in inflammatory infiltrates, and an increase in fibrofatty tissue.” [129]
“The number of taste buds decreases after age 45, resulting in a decrease in taste
sensation...” [130]
Gast roint est inal Syst em
In people over 60, there is an increased prevalence of atrophic gastritis [131].
“Several histologic changes have been demonstrated in the colon, including atrophy of
the muscolaris propria with an increase in the amount of fibrosis and elastin,...” [132]
“Using postmortem material, Chacko et al. (1969) found that in an Indian population the
shape of villi changed on aging. The youngest subjects had finger-shaped villi, but the
frequency of broad villi and convolutions increased in specimens from older people. Webster
and Leeming (1975a) described similar changes when fresh jejunal specimens from geriatric
patients were compared with normal young controls. They found that in the elderly broader
26
Giacinto Libertini
villi were more common, and in addition the villi were significantly shorter. ... Andrew and
Andrew (1957) noticed an increase in the amount of fibrous tissue between the crypts of
Lieberkuhn and a general reduction of cellularity in older mice. ... Lesher, Fry and Kohn
(1961), Lesher and Sacher (1968) and Fry, Lesher and Kohn (1961), using autoradiography
and tritiated thymidine, showed a prolonged generation time for duodenal crypt cells in old
animals and an increased cell transit time (for cells to progress from the crypts to villous tips).
In conclusion, the possible expected age changes in the small bowel of man are an increase in
broad villi, with a reduction in villous height. These changes may be due to reduced cell
production.” [133]
Four to six stem cells for each crypt allow the turnover of the absorptive epithelium of
small intestine [134].
Liver
Liver volume declines with age [135], both in absolute values and in proportion to body
weight [136], and this reduction has been estimated to be about 37 percent between ages 24
and 91 [135]. Liver blood flow also declines with age, by about 53 percent between ages 24
and 91 [135]. However, while liver size declines with age, hepatocytes increase in size, unlike
in the liver atrophy that accompanies starvation [137].
Cirrhosis is the final stage of chronic destruction of hepatocytes caused by hepatitis,
alcoholism or other factors. When hepatocyte stem cells exhaust their duplication capacities,
the liver is transformed by a general atrophic process, often complicated by carcinomas
caused by dysfunctional telomere-induced instability [106,111].
Diabet es
Diabetes frequency increases from youth to old age [138]. Pancreatic β-cells show
turnover [88] and it has been suggested that type 2 diabetes is caused by insufficient
substitution of β-cells killed by metabolic stress [118,119]. In Werner syndrome, diabetes
could be caused by impaired replicative process of β-cell stem cells with an insufficient
replacement of apoptotic β-cells. In normal old individuals, the progressive exhaustion of βcell turnover could justify the age-related progressive frequency of the disease.
Drugs effective in “organ protection”, as ACE-inhibitors and sartans and statins, reduce
the risk of diabetes [139,140].
Heart
In the old heart there is a global loss of myocytes, with a progressive increase in myocyte
cell volume per nucleus [141]. “With aging, there is also a progressive reduction in the
number of pacemaker cells in the sinus node, with 10 percent of the number of cells present at
age 20 remaining at age 75. ... Age-associated left ventricular hypertrophy is caused by an
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
27
increase in the volume but not in the number of cardiac myocytes. Fibroblasts undergo
hyperplasia, and collagen is deposited in the myocardial interstitium.” [142]
The decline of cardiac contractile capacities causes an enlargement of the heart that
conceals the underlying atrophy of the contractile cells.
“... some increase in the amount of fibrous tissue and fat in the atrial myocardium with a
decrease in the number of muscle fibres, and loss of fibres in the bifurcating main bundle of
His and at the junction of the main bundle and its left fascicles, with lesser degrees of loss in
the distal bundle branches.” [143]
Drugs effective in “organ protection”, as ACE-inhibitors, sartans and statins, are effective
in the prevention of atrial fibrillation [144,145].
Lungs
Lung volumes (FEV1, FVC) decline with age [146]. “The most important age-related
change in the large airways is a reduction in the number of glandular epithelial cells ... the
area of the alveoli falls and the alveoli and alveoli ducts enlarge. Function residual capacity,
residual volume, and compliance increase. ...” [147] (Figure 14).
Statin use reduces decline in lung function [148], justified as due to anti-inflammatory
and antioxidant properties [148], but that could be the consequence of effects on type II
alveolar epithelial cells, analogous to those on endothelial cells [117].
Figure 14. Normal lung (left) in comparison with a lung affected by marked emphysema (right).
Kidneys
“Age-induced renal changes are manifested macroscopically by a reduction in weight of
the kidney and a loss of parenchymal mass. According to Oliver, the average combined
weight of the kidneys in different age groups is as follows: 60 years, 250 g; 70 years, 230 g;
80 years, 190 g. The decrease in weight of the kidneys corresponds to a general decrease in
the size and weight of all organs. Microscopically, the most impressive changes are
reductions in the number and size of nephrons. Loss of parenchymal mass leads to a widening
28
Giacinto Libertini
of the interstitial spaces between the tubules. There is also an increase in the interstitial
connective tissue with age. The total number of identifiable glomeruli falls with age, roughly
in accord with the changes in renal weight.” [149]
Microalbuminuria, a simple marker of nephropathy, is “predictive, independently of
traditional risk factors, of all-cause and cardiovascular mortality and CVD events within
groups of patients with diabetes or hypertension, and in the general population ... It may ...
signify systemic endothelial dysfunction that predisposes to future cardiovascular events”
[150], and this implicates that drugs effective in “organ protection” defend renal functionality
too.
Skelet al Muscle
There is positive correlation between age and muscle atrophy, both in terms of overall
muscle bulk and of the size of individual fibers [151,152].
“These changes are to some extent dependent on the fallout of anterior horn cells that
occurs with age, but this does not completely explain the process of aging atrophy. In detailed
studies it has been shown that the progressive reduction that occurs in muscle volume with
aging can be detected from age 25 years and that up to 10 percent of muscle volume is lost by
age 50 years. Thereafter the rate of muscle volume atrophy increases, so that by 80 years
almost half the muscle has wasted. ... Both reduction in fiber number and fiber size are
implicated in the loss of muscle volume.” [153]
In Duchenne muscular dystrophy, there is a chronic destruction of myocytes that are
continually replaced by the action of stem cells until these are exhausted [104].
Bone
“Once middle age is reached, the total amount of calcium in the skeleton (i.e., bone mass)
starts to decline with age ... This is associated with changes in skeletal structure, resulting in it
becoming weaker and more prone to sustaining fractures. For example, the bony cortex
becomes thinner due to expansion of the inner medullary cavity, the trabecular network
disintegrates, and there is an accumulation of microfractures. ... Bone loss in the elderly is
largely a result of excess osteoclast activity, which causes both an expansion in the total
number of remodelling sites and an increase in the amount of bone resorbed per individual
site. .... Bone loss in the elderly is also thought to involve an age-related decline in the
recruitment and synthetic capacity of osteoblasts” [154] (Figure 15).
“Involutional bone loss ... starts between the ages of 35 and 40 in both sexes, but in
women there is an acceleration of bone loss in the decade after menopause. Overall, women
lose 35 to 50 percent of trabecular and 25 to 30 percent of cortical bone mass with advancing
age, whereas men lose 15 to 45 percent of trabecular and 5 to 15 percent of cortical bone. ...
Bone loss starts between the ages of 35 and 40 years in both sexes, possibly related to
impaired new bone formation, due to declining osteoblast function.” [155]
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
29
Figure 15. A normal vertebra (left) in comparison with an osteoporotic vertebra (right). The bones of
elders are sometimes described wrongly as worn-out while they are clearly atrophic.
Blood
“... red cell indexes are well preserved even in centenarians. ... peripheral blood
lymphocyte populations do seem to show a significant change in age, with a fall in total
numbers. CD4+ T-helper cells, responsible for major histocompatibility complex class II
restricted recognition of foreign antigen and subsequent activation of CD8+ T-suppressor, Blymphocyte, and granulocyte effector cells of the immune response, show an overall decline
with age accompanied by a reduction in capacity to produce virgin CD4+ CD45RA T cells. ...
Gradual involution of red marrow continues but is especially marked after the age of 70 years
when iliac crest marrow cellularity is reduced to about 30 percent of that found in young
adults.” [156]
In vitro neutrophil functions (e. g: endothelial adherence, migration and phagocytosis
capacity, granule secretory behavior, etc.) are insignificantly affected by age but in vivo
significantly fewer neutrophils arrive at the skin abrasion sites studied in older people [157].
The proliferative capacity of T lymphocytes to nonspecific mitogens is greatly reduced with
aging [158].
It has been suggested that age-related functional decline in adult tissue hematopoietic
stem cells limits longevity in mammals [159].
Brain
“...brain weight, on average, remains fairly constant up until 60 years of age, after which
a gradual decline sets in leading to an eventual loss of only some 5 percent of the original
weight (60 to 70 g) by the ninth decade. ... progressive decline in nerve cell number with
aging in areas such as the temporal cortex (middle and inferior temporal gyri), the pre- and
post-central gyrus, the striate cortex, and the inferior and superior frontal cortex, leading to
average overall losses in old age ranging from about 10 to 50 percent with the greatest
changes occurring in the frontal and temporal cortex.” [160].
Neurones have no turnover but their survival depends on other cells with turnover, in
particular endothelial cells of cerebral arteries and gliocytes [74] (see next paragraph).
30
Giacinto Libertini
Cancer
A thorough review [106] illustrates the well documented hypothesis of telomere
dysfunction as an important cause of cancer in old age, especially for cells with higher
turnover that are for the most part epithelial.
Cells / Tissues wit h No Turnover
Crystalline Lens
See discussion about Werner syndrome, argument 1. Besides, statin use lowers risk of
nuclear cataract, the most common type of age-related cataract [161]. This has been attributed
to “putative antioxidant properties” [161] but could be the consequence of effects on lens
epithelial cells analogous to those on endothelial cells [117].
Phot orecept or Cells ( Cones and Rods)
Retina cones and rods are highly differentiated nervous cells with no turnover. The top of
these cells leans on retina pigmented cells, highly differentiated gliocytes with a turnover rate
that declines with age (Figure 16). Each day 10% of the membrane on which photopsin
molecules lie are phagocytized by retina pigmented cells and substituted by an equal quantity
of new membrane. Each retina pigmented cell serves 50 cones or rods and, therefore, each
day a cell metabolises photopsin molecules of about 5 cones or rods, demonstrating a very
high metabolic activity. Without the macrophagic activity of retina pigmented cells,
photoreceptor cells cannot survive. Replicative senescence and cell senescence of retina
pigmented cells limit or stop the functionality of retina cones and rods and then cause their
death, i.e. age-related retina macular degeneration (AMD) [162].
With particular deficiencies of retina pigmented cells, AMD arises at lower ages and is
considered a specific disease while at later ages its frequency increases exponentially and is
considered a feature of the senile state.
Indeed, AMD affects 5%, 10% and 20%, respectively of subjects 60, 70 and 80 years old
[163] and it is likely that a large proportion of centenarians suffer from AMD.
Smoking, diabetes, and obesity are risk factors for AMD [164].
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
31
Figure 16. A scheme of a photoreceptor and of a retina pigmented cell.
Neurons
As photoreceptor cells, specialized types of neurons with no turnover, depend on other
cells that are specialized types of gliocytes with turnover, perhaps other types of neurons
depend from other types of gliocytes.
If this it true, replicative senescence and cell senescence of these gliocytes should cause
pathologies similar to AMD. Without the key example of AMD, it has been already
hypothesised that Alzheimer disease is dependent from the decline of the function of
particular gliocytes (microglia cells) because of the failure of the telomere-telomerase system
[74]: “One function of the microglia (Vekrellis et al., 2000) is degradation of β-amyloid
through insulin-degrading enzyme (IDE), a function known to falter in Alzheimer disease
(Bertram et al., 2000” (p. 233), “telomere lengths of circulating monocytes can serve as an
independent predictor in at least vascular dementia (von Zglinicki et al., 2000b)” (p. 235), “A
cell senescence model might explain Alzheimer dementia without primary vascular
involvement.” (p. 235). As for AMD, there are precocious familial cases of Alzheimers,
considered as distinct diseases with distinct genetic causes [74], and Alzheimer frequency
increases exponentially with age: 1,5% at age 65 years and 30% at 80 [165], with a very high
probability that a centenarians is affected by it. There is also an association between
Alzheimer disease and cardiovascular factors [166]. Drugs with organ protection qualities
such as statins, ACE-inhibitors and sartans, are effective against Alzheimer disease too [167].
Discarding the simplistic deduction that Alzheimer disease is only a consequence of
vascular dysfunction, it is likely that there is a common pathogenetic mechanism: endothelial
dysfunction caused by low endothelial progenitor cells in the first case, and microglia
dysfunction caused by low microglia progenitor cells in the second case. In both cases the
telomere-telomerase system is the primary causal factor and cardiovascular / Alzheimer risk
factors accelerate telomere failure, whereas “protective” drugs counter these effects (see
Figure 17).
32
Giacinto Libertini
A General Schem e
Factors that, for the turnover of each cell type, increase and reduce apoptosis rates should
accelerate and slacken, respectively, the physiological age-related decline in turnover and,
therefore, the onset of the related function decline (Figure 17 and Table III).
Figure 17. A general scheme for the onset of various diseases. For example, apoptotic rate of
endothelial cells is influenced by age as well as changes in the relative risk factors. It is the precise
combination of these factors which determines the timing of vascular disease onset.
Table III. Abbreviations: WS = Werner syndrome; DC = dyskeratosis congenita;
→ X = causing X or accelerating its onset
STEM CELLS OF ...
Alveolar type II cells
ALTERATIONS IN
THE ELDERS
Emphysema
Cardiac myocytes
Endothelial cells
Cardiac insufficiency
Atherosclerosis
Epidermis cells
Skin atrophy
Glomerular cells
Renal insufficiency
Hepatocytes
Hepatic atrophy
Intestinal cells
Lens epithelial cells
Microglia cells
Intestinal atrophy
Cataract
Alzheimer disease
Myocytes
Muscle atrophy
Osteoblasts
Pancreatic β-cells
Osteoporosis
Latent or mild diabetes
Retina pigmented cells
AMD
APOPTOSIS INCREASING FACTORS
AND THEIR EFFECTS
Smoking, chronic inhalation of noxious
substances, chronic bronchitis (→ emphysema);
DC (→ fibrosis)
Myocarditis (→ dilatative cardiomyopathy)
Smoking, hypertension, hypercholesteremia,
diabetes; WS (→ atherosclerosis)
Excessive sun exposure (→ photoaging); DC (→
abnormal pigmentation, nail dystrophy); WS (→
skin atrophy)
The same as for endothelial cells (→ renal
insufficiency)
Chronic hepatitis, alcoholism; DC (→ cirrhosis,
hepatic carcinoma)
DC (→ gut disorders)
Exposure to radiations; WS (→ cataract)
The same as for endothelial cells (→ Alzheimer
disease)
Specific genetic defects (→ muscular
dystrophies); WS (→ muscle atrophy)
WS (→ osteoporosis)
Hyperalimentation, specific viral infections; WS
(→ diabetes)
Smoking, obesity, diabetes (→ AMD)
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
33
A Ba dly I nt e r pre t e d Cue :
Te lom e re - Te lom e r a se Syst e m
a s Oncoge nic Fa ct or
If an age-related fitness decline is adaptive, then the existence of sophisticated
mechanisms causing this decline, namely the telomere-telomerase system, is indispensable.
Conversely, if an age-related fitness decline is nonadaptive, the telomere-telomerase
system needs a plausible and detailed evolutionary explanation for its existence [41].
A speculative justification for the effects (replicative senescence and cell senescence) of
the above said system is that of a general defense against the threat of malignant tumors
[168,169], in a sort of evolutionary trade-off between aging and cancer restriction [170].
However, this hypothesis does not justify the great differences in duplication limits and
overall cell functionality decay from species to species, unless the risk of malignant tumors is
postulated as varying from species to species in direct correlation with the limits imposed to
cell duplication capacities and to overall cell functionality by the genetic modulation of
telomere-telomerase system.
Moreover, there are a number of other problems with the hypothesis that the telomeretelomerase system is a defense against cancer:
1) Lobsters and old rainbow trout, “animals with negligible senescence”, have, in the
wild, the same levels of telomerase activity as young individuals [171,172] and
increasing problems of carcinogenesis at older ages are not plausible for them
because, as their definition states, their mortality rates do not increase with age [41].
For these animals, telomerase action involves no evident oncogenic risk and,
therefore the idea that telomerase has an oncogenic effect is implausible in these
species.
2) The decline of duplication capacities and of overall cell functionality weakens
immune system efficiency [74], which has, for a long time, been known to be
inversely related to cancer incidence [173];
3) When telomeres are shortened, there is a great vulnerability to cancer because of
dysfunctional telomere-induced instability [106,111];
4) “The role of the telomere in chromosomal stability (Blagosklonny, 2001; Campisi et
al., 2001; Hackett et al., 2001) argues that telomerase protects against carcinogenesis
(Chang et al., 2001; Gisselsson et al., 2001), especially early in carcinogenesis when
genetic stability is critical (Elmore and Holt, 2000; Kim and Hruszkewycz, 2001;
Rudolph et al., 2001), as well as protecting against aneuploidy and secondary
speciation (Pathak et al., 2002). The role of telomerase depends on the stage of
malignancy as well as cofactors (Oshmura et al., 2000); expression is late and
permissive, not causal (Seger et al., 2002).” [74];
5) The telomere-telomerase system of yeast (Saccharomyces cerevisiae), a unicellular
organism, is well studied. Individuals of this species stop their replications after 2535 duplications [174] that is they show replicative senescence and cell senescence,
although not caused by telomere shortening but by another unknown mechanism
related to the number of duplications [175]. A senescent yeast cell ends its life with
apoptosis [176] and apoptosis is also triggered in difficult conditions [82]. In both
34
Giacinto Libertini
cases, apoptosis divides the cell into metabolically active parts that are usefully and
easily phagocytized by other yeast cells. This is done in an orderly way and such
behavior has been plausibly interpreted as adaptive [43,44,177,178,179,180].
However, in 1988 it was hypothesized that life limiting mechanisms should be
favored in conditions of K-selection, namely: a) with a population numerically
constant, as a consequence of a limited living-space, so that only when an individual
dies there is place for a new individual; b) with dead individuals replaced prevalently
by kin individuals [39]. Colonies of kin yeast cells in a saturated habitat are in these
conditions and, therefore, empirical evidence for yeast is a confirmation of this
theoretical prediction. In yeast, apoptosis, replicative senescence and cell senescence,
determined by genes killing individuals where they act (= negative individual fitness)
are shaped by natural selection with clear adaptive aims (= positive inclusive, or however – supraindividual, fitness) and it is inexplicable that while these phenomena
are accepted as adaptive for unicellular species, the same explanation is not
considered possible for multicellular species [17]. Finally, given that yeast is a
unicellular organism, the telomere-telomerase system and its actions in this species
cannot have any value against cancer: the oncogenic risk is non-existent.
In short, the telomere-telomerase system is hardly justifiable as a defense against cancer
risk and, lacking other explanations, only the adaptive hypothesis of age-related fitness
decline appears a rational cause for its existence.
An Equivoca l Cue :
The Confusion be t w e e n Age - Re la t e d Fit ne ss
D e cline in t he W ild a nd M or t a lit y I ncr e a se in
La bor a t or y Condit ions
In figures 18-A1 and 18-A2, are the life tables of wild species such as the lion (Panthera
leo) and hippopotamus (Hippopothamus amphibius), which demonstrate an age-related
mortality increment in natural conditions. These life tables are examples among very many
species, our species included, demonstrating the same phenomenon. For brevity, this
“increment of mortality with increasing chronological age in the wild” has been called
IMICAW [39].
In figures 18-B1 and 18-B2, are the life tables of animals in laboratory conditions, such
as the nematode Caenorhabditis elegans [181] and the fly Drosophila melanogaster [182],
which in artificial conditions demonstrate an age-related mortality increment. These life
tables are examples among very many species, most of insects included, demonstrating an
analogous age-related mortality increment in artificial protected conditions. For brevity, this
“increment of mortality with increasing chronological age in captivity” has been called
IMICAC [39].
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
35
A superficial observer could suppose that IMICAW and IMICAC are the same
phenomenon and therefore studies more easily done on the worm or on the fly could explain
what happens in species such as the lion, hippopotamus and man.
However, a well-informed observer knows that the ages in which mortality increment
starts in laboratory for the worm and for the fly, do not exist in the wild. In fact, the longevity
of Caenorhabditis elegans “under more natural conditions is reduced up to 10 fold compared
with standard laboratory culture conditions” [183] and few individuals of this species remain
fertile in the wild after 10 days [184]. Similarly, Drosophila melanogaster has a reported
adult life span in the wild of 10-12 days [181].
For both these animals, the age-related increasing mortality described in figures 18-B1
and 18-B2 starts at ages non-existent in the wild, meaning that it is no more than a laboratory
artefact.
Well, if IMICAW exists by definition in the wild and therefore by definition is influenced
by natural selection, while on the contrary IMICAC is non-existent in the wild and therefore
is not influenced by natural selection, we should have strong doubts about the conclusions of
experiments about IMICAC applied to IMICAW. However, there is another essential
difference.
The worm and the fly (and in general the adult insects) are composed of cells with no
turnover [181,185], while lion, hippopotamus and man have cells and tissues with turnover.
If, as it seems probable, the slowdown and later the stopping of cell turnover, and the
correlated cell senescence, are pivotal elements in the fitness decline of animals such as the
lion, hippopotamus and our species, it is rather dubious to use experiments on animals with
no cell turnover to explain the fitness decline in animals with cell turnover. This is a basic
problem, certainly of extreme weight for those interested in the explanation of aging
mechanisms. However, in renowned texts on the topic, the problem is not considered [24],
and it is frequent that, in very influential journals, experiments modifying the life table of our
dear worm or of our beloved fly are presented as meaningful advances in the understanding of
human aging [186,187,188]!
36
Figure 18. (Continued).
Giacinto Libertini
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
37
Figure 18. Life table and death rate of: (A1) lion (Panthera leo) in the wild, data from Ricklefs [9];
(A2) hippopotamus (Hippopotamus amphibius) in the wild, data from Ricklefs[9]; (B1) Caenorhabditis
elegans reared in laboratory, data from Finch, Figure 6.1 [181]; (B2) Drosophila melanogaster reared
in laboratory, data from Finch and Hayflick, Figure 10 [182].
A Sur pr ising Cue :
Anim a ls w it h N e gligible Se ne sce nce
“Negligible senescence” has been defined as the condition of species — such as rockfish,
sturgeon, turtles, bivalves and possibly lobsters [189] — which show in the wild “no
observable increase in age-specific mortality rate or decrease in reproduction rate after sexual
maturity; and … no observable age-related decline in physiological capacity or disease
38
Giacinto Libertini
resistance” [189]. In some cases fitness even increases with age, i.e. as a function of
increasing body size [190].
For a theory explaining age-related fitness decline as the result of harmful factors that
accumulate with the passing of time and are not sufficiently opposed by natural selection, the
existence of animals reaching very old ages in the wild without any observable decline in
their fitness, is a true challenge by no means solved by current theories of aging (“negligible
senescence … may be in conflict with mathematical deductions from population genetics
theory” [189]). For such a theory, ageless animals have to be explained as exceptions justified
by hypothetical not documented physiologic peculiarities. Particular optimization models of
life-history strategies, based on the suppositions of disposable soma theory [25,26] have been
developed to justify even the cases of negative senescence [190].
On the contrary, for a theory explaining age-related fitness decline as caused in particular
conditions by selective factors, there is a simple prediction: a species that is not in those
particular conditions must be an ageless animal. This means that, for these species, survival in
the wild (disregarding possible minor factors that modify fitness) is described by the simple
formula:
Y t = Y 0 ⋅ (1 – λ)t
(4)
where Y 0 is the initial population, Y t are the survivors at time t and λ is the mortality rate.
Survival is determined only by the parameter λ. With low values of λ, it is predicted that,
in the wild, some individuals will reach very old ages. For example, if λ = 0,011306 / year,
the survivors after 405 years will be about 1% and the case of Arctica islandica specimen
with an age of 405 years retrieved near Iceland in 2007 will not result surprising.
However, at an age t reached in the wild by few or no individuals, there is very little or
no natural selection against a gene with harmful action only at that age (“t-gene”). Therefore,
by the cumulative effects of various “t-genes”, if a species demonstrating no age-related
fitness decline in the wild is reared in protected conditions, it could show a progressive
increase in mortality starting from ages rarely or never existing in the wild. In other words,
the species could show IMICAC phenomenon (Figure 19).
As a simple corollary of formula (4) and of this phenomenon, for a group of species of
the same genus, all in conditions not favouring the fitness decline, it is predicted that: (1) all
species will have a stable fitness at all ages existing in the wild, with a possible little
decrement at ages rarely present in the wild; (2) for each species mean life span and
maximum life span in the wild will be inversely correlated with λ; (3) in protected conditions,
for each species life span will be determined by variable factors, which could increase
mortality starting from ages rarely or never existing in the wild and therefore variable from
species to species and inversely correlated with λ. Life tables of the rockfish genus are
probably a good example of these predictions [191].
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
39
A
B
Figure 19. Results obtained with a simulation program (IMICAC.exe [40], available at the
Internet address www.r-site.org/ageing/simprograms.zip). (A) A species with a constant extrinsic
mortality rate in the wild (=0.2 / unity of time), plus the small increase of mortality rate, at ages rarely
or never existing in the wild, due to the action of t-genes (20 in the simulation and with a mutation rate
from inactive alleles equal to 0.00001); (B) The same species, in protected conditions with a zero
extrinsic mortality rate, shows the IMICAC phenomenon due to the action of t-genes at ages notexisting in the wild.
It is interesting that for the rockfish genus, telomerase activity is constant at all ages
existing in the wild [171,172]. Moreover, for two species of rockfish, it has been observed
that oogenesis continues at advanced ages, in contrast with long-held assumptions [192].
A rockfish is showed in Figure 20.
40
Giacinto Libertini
Figure 20. A rockfish. Image from the site www.agelessanimals.org, a scientific site, directed by John
C. Guerin and dedicated to: Emerging Area of Aging Research: Long-lived Animals with "Negligible
Senescence".
A Poor ly Unde rst ood Cue : Aging a s D ist inct Ent it y
It is very common to hear from ordinary people that someone died due to old age.
However, in the official statistics no one dies due to old age! In the compilation of official
death certificates, in any nation of the world, a physician, as I am, must use the international
classification of diseases (ICD), in which, though there are codes for “senile dementia” or
“senile cataract”, a codification for “aging” or “senescence” is non-existent. Some years ago,
I compiled the death certificate for a 102-year-old great-grandmother who had no particular
disease, but I could not write that she was died because she was old!
A very authoritative gerontologist wrote to me on the subject, saying: “The question you
are asking me is an old one - should senescence be listed on the death certificate of someone
who dies past the age of 100.
For some people for whom it is not possible to find an underlying cause, such as
individuals who experience what would appear to be a collapse of their entire body all at one,
I would say that senescence would be an appropriate cause of death to place as the underlying
cause.
I expect the frequency of this diagnosis will increase in the coming decades. However,
should such a cause of death be added to the ICD, my guess is that it would overused by
attending physicians too lazy to determine underlying cause.”
Aging as a distinct cause of death is disregarded or considered as non-existent by classic
gerontological theories or by official epidemiology. For such theories, aging is not a specific
process but only the sum of many different diseases (Figure 21). With this paradigm, we
should cure each of these diseases, while the possibility of acting on aging is unthinkable
because aging does not exist as a distinct entity!
Well, if you want to understand the next paragraphs, you should accept a new idea, a
radical change of the old paradigm that “gradual decline in performance with age happens by
default” [193]: i.e. aging as a distinct phenomenon exists!
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
41
Figure 21. According to the classic paradigm, these elders will not be killed by senescence but only by
a myriad of diseases whose frequency increases with age.
Ancie nt a nd Cur r e nt Sce ne r y:
Tow a rd a Socio- M e dica l N ight m a r e
Until the beginning of the XIX century the child mortality rate was very high, the adult
mortality rate was higher than present and the mortality rate for elders not very different from
present. The following is an example of this historical child mortality rate. In the years 18121815, in the statistics from a part of the reign of Naples under king Murat [194] the number of
those who died before 7 years of age was about 42-46% of the total of deaths, e.g.:
Table IV. Mortality in Naples and province at the beginning of XIX century
1812
1813
1814
1815
(Province of Naples)
“
“
(City of Naples)
< 7 years old
3.821 (42.62%)
4.420 (45.44%)
4.367 (45.24%)
5.600 (42.22%)
> 7 years old
5.144
5.308
5.287
7.664
Total
8.965
9.728
9.654
13.264
In the next 200 years with the large improvement in economic and hygienic conditions
and with the advances in medical cure, there has been a drastic lowering of children’s
mortality, a strong reduction of adult mortality and a relatively modest increase in life
expectancy for the elders. The triplication of mean life span in these two centuries (from
about 25 years in 1800 to about 75 years today) is due largely to a drastic reduction in
children’s mortality and contrasts strongly with an apparently stable maximum life span. This
is shown for England in Figure 22, which indicates that the survival table is becoming similar
42
Giacinto Libertini
to that of a straight line followed by a sharp drop (rectangular curve). With the increasing
control of tumoral, cardiovascular and other diseases (and an exponential increase in related
costs), a greater rectangularization of the survival curve is a realistic forecast for the next
decades.
Figure 22. Survival curves for cohorts of one thousand newborns, by age group: England, 1541-1991.
Data from Cambridge Group back projection files and English Life tables up to no. 15. Work of James
Oeppen. From: Kertzer, David I., and Peter Laslett, editors Aging in the Past: Demography, Society,
and Old Age. Berkeley: University of California Press, c1995 1995. http://ark.cdlib.org/ark:/
13030/ft096n99tf/.
This means that the population will be comprised of an increasing number of elderly
individuals with severe troubles and pains deriving from marked osteoporosis, harsh
cardiovascular and respiratory insufficiency, senile dementia, visual and auditive deficits,
incontinence, etc. In short, an increasing part of the population will be seriously suffering
from many diseases, in particular for the decay of cognitive and sensory capacities, and they
will therefore be dependent on others. This will have heavy economic results. The progress of
medicine will become the cause of a sociological and economic nightmare.
In a sense it will be the realisation of the legend of Aurora and Tithonus. Aurora, a
goddess, obtained the gift of immortality from Jupiter for her beloved Tithonus, a mortal man,
but neglected to ask for perpetual youth. Tithonus became older and older and never died.
Lastly, out of pity, Tithonus was transformed in an animal. In 1979, Comfort said: “We are
producing Tithonuses” [195]!
Today, we could say that a mass production of Tithonuses has been started.
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
43
A Possible Alt e r na t ive Sce ne ry: Tow a rd t he
Ta m ing of Se ne sce nce
We have two opposite general hypotheses, or paradigms, about the fitness decline and its
extreme expression, i.e. ‘old age’ or the ‘senile state’.
For the first paradigm, the phenomenon is something inescapable, inevitably inherent to
the nature of life and weakly opposed by repair mechanisms in the tight limits of other
prevailing demands dictated by natural selection. To counter senescence is as to oppose the
force of gravity in the construction of a skyscraper: the higher one goes, the exponentially
greater are the necessary efforts. In other words, the undertaking of this task becomes
impossible beyond certain heights.
For the second paradigm, fitness decline is a function: suitable mechanisms, which are
genetically determined and favoured by evolution because of their positive inclusive fitness,
limit life span. Opposing senescence is like removing the obstacles or limiting the friction
beneath a ball that rushes on a flat surface. Clearly the natural condition of such a moving
body - in absence of friction and other obstacles - is an unlimited movement.
According to the first paradigm, the interpretation of senescence as a program is an
absurdity because it would be of no evolutionary meaning. Therefore, the growing evidence
in support of such a program is disregarded and attention is fixed only on the stochastic
accumulation of damages of various types.
Conversely, according to the second paradigm a program is not at all excluded. In fact,
without a program the second paradigm would be false, and attention is fixed on the events
that actively determine and regulate the progressive fitness reduction. Moreover, as aging is
the consequence of genetically determined mechanisms and not the sum of stochastic events,
such mechanisms are the rational object of useful analysis and of possible control and
modification. What for the first paradigm is an insuperable obstacle and a closed horizon, for
the second paradigm is a modifiable and controllable trait, one with a limitless horizon.
To master the senile state, apart from foreseeable crucial objections of bioethical or
philosophical or religious nature that will be outlined immediately after, three categories of
action are required:
1) Alterations due to cell turnover limitations - A thorough knowledge of the mechanisms
underlying cell turnover and its limitations are needed. Currently, drugs with “organ
protection” properties seem to act efficaciously on some cell turnover alterations [117]. It
seems more rational to propose as a future treatment the modification of regulating genes
before the onset of aging manifestations, in a sort of gene “therapy”. Incidentally, the term
“therapy” is open to criticism since age-related fitness decline not properly a disease. Ten
years ago extraordinary experiments demonstrated that the insertion of an active telomerase
gene or, in general, telomerase activation, eliminates replicative senescence and the effects of
cell senescence [65,66,69]. This indicates that the effects of many factors on aging, oxidative
substances included, are reversible consequences of cell senescence and not the cause of
aging [74].
Presently, gene therapy is possible, or in trial, for only a few diseases and with the
insertion of the appropriate gene in a random DNA position [196,197,198], therefore with the
possible noxious modifications of other genes, e.g., oncogene suppressors (Figure 23). This is
a strong contraindication for an indiscriminate use of this therapeutic technique.
44
Giacinto Libertini
Figure 23. The insertion of a DNA sequence in a random point may cause damage that is fatal for the
whole organism, e.g. inactivating an oncogene repressor.
Furthermore, to limit this danger, the gene is inserted in only a fraction of cells that, if
somatic, are substituted by turnover, which gradually cancels the therapeutic effects. Ideally,
gene therapy should recognise a known sequence with no function and present as unique copy
in the whole DNA and then, with a safe vector, insert the gene, breaking the known sequence
in a precise point so that a second insertion would be impossible because the known sequence
is modified (Figure 24). Moreover, the gene should be inserted in the majority, or prefereably
all, cells (stem cells included) so that its elimination by cell turnover would be avoided. With
these specifications, apart from any possible bioethical objections, gene therapy in non-germ
line cells could be proposed to modify telomere-telomerase system so that age-related fitness
decline will be postponed or even nullified.
Later, the possible application of the same techniques to germ line cells, namely the
possibility to obtain a status of “negligible senescence”, probably will become only a
bioethical / philosophical / religious problem.
2) Age-associated diseases – At ages rarely or never present in the wild, natural selection
against genes causing a disease is weak or non-existent. Such diseases can be defined as “age
associated disease” because they are an evolutionary consequence of age-related increasing
mortality in the wild. A thorough knowledge of each of the associated diseases is a plain
preliminary condition. The next step is the achievement of treatments to completely control
each of them, namely avoiding that with growing age their harm, even if reduced,
accumulates. However, as age-associated diseases are very common in the elderly [199] and
the coexistence of diverse age-associated diseases in the same individual is common [199].
For this reason, the modification of the altered genes before the beginning of the symptoms
seems the ideal treatment. About gene therapy, see the preceding paragraph.
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
45
Figure 24. The sequence is inserted breaking a known sequence existing as a unique copy in the whole
genome and with no function. The breaking of this unique sequence makes impossible another gene
insertion in the same cell.
3) Alterations due to wear and tear factors - The main example of this is tooth wear.
Besides their replacement with prosthesis, multiple dentitions, namely a periodic tooth
renewal as is found in other species, is imaginable. “The senescence of human teeth consists
not of their wearing out but of their lack of replacement when worn out.” [23]. Thus period
tooth renewal would be possible by means of germ line cell modifications, although the
aforementioned ethical objections would still remain.
Bioethical / philosophical / religious objections. The possible treatments mentioned
above pose great technical obstacles, none of them in principle insuperable, but there are two
much greater problems, the solutions to which are not at all scientific or technical (Figure 25):
I.
The first is that to modify natural aging to a slower or even a zero rate (negligible
senescence) constitutes an enormous change of human nature, and is not merely the
correction of a disease. For this, and even more for any hypothesis of germ cell
modification, it is easy to anticipate strong bioethical, philosophical or religious
objections, or even accusations of blasphemyNote 1 or of ύβριςNote 2.
II. The second, still greater, difficulty, is that changes in civilisation resulting from
senescence slowing or even from a non-senescent condition, would certainly be
extreme and full of uncertainties. The roots of our civilisation, organisational
structure and cultural traditions are based upon the philosophical idea and religious
creed that life span limitation is ineluctable. The drastic change of such a reality
would be a revolution greater than any other revolution ever experienced by our
species.
46
Giacinto Libertini
Figure 25. To act, or not to act on telomere-telomerase system: that is the question.
The N e e d of a N e w D r a m a t urgy: Conclusion
The change of an ancient paradigm seems indispensable. Age-related increasing mortality
is not an unavoidable fate, as the old paradigm claims. To the contrary, it is a trait, the
underlying mechanisms of which can now be described in precise detail, which has been
actively moulded by selection. Although such a trait seems paradoxical because it does not
improve individual fitness, the hypothesis that it has been moulded by selection means that it
is modifiable and tameable in principle. The old paradigm considers fitness decline to be a
maladaptive character that can only be partially opposed [200]. By considering aging as “a
specific biological function” [42], then, the new paradigm offers a more optimistic approach
to treating aging.
However, the change of a paradigm is always a scientific revolution and this usually
requires a new generation [201].
Note 1) "Then God said, 'Let Us make man in Our image, after Our likeness ...." Genesis
1:26; "So God created man in His own image, in the image of God He created Him ..."
Genesis 1:27.
Note 2) In the Greek classic culture a mortal that presumed to measure himself against
the gods, regarding himself or searching for being like to them, became guilty of ύβρις,
namely of unforgivable impious pride and arrogance toward the deity.
Aknowledgements: I thank Lucy Milewski for her helpful correction of my weak English
and some useful criticisms.
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
47
Re fe re nce s
[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[10]
[11]
[12]
[13]
[14]
[15]
[16]
[17]
[18]
[19]
[20]
Darwin C. (1871) The descent of man, and selection in relation to sex. Appleton, New
York (USA).
Deevey E.S.Jr. (1947) Life tables for natural populations of animals. Quart. Rev. Biol.
22, 283-314.
Laws R.M. (1966). Age criteria for the African elephant, Loxodonta a. africana. E. Afr.
Wildl. J. 4, 1-37.
Laws R.M. (1968). Dentition and ageing of the hippopotamus. E. Afr. Wildl. J. 6, 1952.
Laws R.M. and Parker I.S.C. (1968) Recent studies on elephant populations in East
Africa. Symp. Zool. Soc. Lond. 21, 319-59.
Spinage C.A. (1970) Population dynamics of the Uganda Defassa Waterbuck (Kobus
defassa Ugandae Neumann) in the Queen Elizabeth park, Uganda. J. Anim. Ecol. 39,
51-78.
Spinage C.A. (1972) African ungulate life tables. Ecology 53, 645-52.
Holmes D.J. and Austad S.N. (1995) Birds as Animal Models for the Comparative
Biology of Aging: A Prospectus. J. Geront.: Biological Sciences 50A, B59-66.
Ricklefs R.E. (1998) Evolutionary theories of aging: confirmation of a fundamental
prediction, with implications for the genetic basis and evolution of life span. Am. Nat.
152, 24-44.
Goldsmith T.C. (2003) The Evolution of Aging: How Darwin's Dilemma is Affecting
Your Chance for a Longer and Healthier Life, iUniverse, Lincoln, Nebraska (USA).
Weismann A. (1889, 2nd edn 1891). Essays Upon Heredity and Kindred Biological
Problems. Vol. I. Oxford, Clarendon Press (UK).
Kirkwood T.B.L. and Cremer T. (1982) Cytogerontology Since 1881: A Reappraisal of
August Weissmann and a Review of Modern Progress. Hum. Genet. 60, 101-21.
Weismann A. (1892). Essays Upon Heredity and Kindred Biological Problems. Vol. II.
Oxford, Clarendon Press (UK).
Carrel A. (1913) Contributions to the study of the mechanism of the growth of
connective tissue. J. Exp. Med. 18, 287-299.
Shay J.W. and Wright W.E. (2000) Hayflick, his limit, and cellular ageing. Nat. Rev.
Mol. Cell. Biol. 1, 72-6.
Hayflick L. (1977) The cellular basis for biological aging. In: Handbook of the biology
of aging. Finch C.E. and Hayflick L., Van Nostrand Reinhold Company, New York
(USA).
Kirkwood T.B.L. and Austad, S.N. (2000) Why do we age? Nature 408, 233-8.
Medawar P.B. (1952) An Unsolved Problem in Biology. H. K. Lewis, London.
Reprinted in: Medawar, P.B. (1957) The Uniqueness of the Individual, Methuen,
London.
Hamilton W.D. (1966) The Moulding of Senescence by Natural Selection. J. Theor.
Biol. 12, 12-45.
Edney E.B. and Gill R.W. (1968) Evolution of Senescence and Specific Longevity.
Nature 220, 281-2.
48
Giacinto Libertini
[21] Mueller L.D. (1987) Evolution of accelerated senescence in laboratory populations of
Drosophila. Proc. Natl. Acad. Sci. USA 84, 1974-7.
[22] Partridge L. and Barton N.H. (1993) Optimality, mutation and the evolution of ageing.
Nature 362, 305-11.
[23] Williams G.C. (1957) Pleiotropy, natural selection and the evolution of senescence.
Evolution 11, 398-411.
[24] Rose M.R. (1991) Evolutionary biology of aging. Oxford University Press, New York
(USA).
[25] Kirkwood T.B.L. (1977) Evolution of ageing. Nature 270, 301-4.
[26] Kirkwood T.B.L. and Holliday R. (1979) The evolution of ageing and longevity. Proc.
R. Soc. Lond. B 205, 531-46.
[27] Hayflick L. (2000) The future of ageing. Nature 408, 267-9.
[28] Leopold AC. (1961). Senescence in plant development. Science 134, 1727-32.
[29] Woolhouse H.W. (1967). The nature of senescence in plants. Symp. Soc. Exp. Biol. 21,
179-213.
[30] Maynard Smith J. (1964) Group selection and kin selection. Nature 201, 1145-7.
[31] Maynard Smith J. (1976) Group selection. Quart. Rev. Biol. 51, 277-83.
[32] Hamilton W.D. (1964) The Genetical Evolution of Social Behaviour, I, II. J. Theor.
Biol. 7, 1-52.
[33] Hamilton W.D. (1970) Selfish and Spiteful Behaviour in an Evolutionary Model.
Nature 228, 1218-20.
[34] Trivers R.L. (1971) The evolution of reciprocal altruism. Quart. Rev. Biol. 46, 35-57.
[35] Wilson E.O. (1975) Sociobiology, The New Synthesis. Harvard University Press,
Cambridge (UK).
[36] Trivers R.L. and Hare H. (1976). Haploidiploidy and the evolution of the social insect.
Science 191, 249-63.
[37] Pianka E.R. (1970). On r- and K-selection. Amer. Natur. 104, 592-7.
[38] Libertini G. (1983) [Evolutionary Arguments] [Book in Italian]. Società Editrice
Napoletana, Naples (Italy).
[39] Libertini G. (1988) An Adaptive Theory of the Increasing Mortality with Increasing
Chronological Age in Populations in the Wild. J. Theor. Biol. 132, 145-62.
[40] Libertini G. (2006) Evolutionary explanations of the “actuarial senescence in the wild”
and of the “state of senility”. TheScientificWorldJOURNAL 6, 1086-108 DOI
10.1100/tsw.2006.209.
[41] Libertini G. (2008) Empirical evidence for various evolutionary hypotheses on species
demonstrating increasing mortality with increasing chronological age in the wild.
TheScientificWorldJOURNAL 8, 182-93 DOI 10.1100/tsw.2008.36.
[42] Skulachev V.P. (1997) Aging is a specific biological function rather than the result of a
disorder in complex living systems: biochemical evidence in support of Weismann's
hypothesis. Biochemistry (Mosc). 62, 1191-5.
[43] Longo V.D., Mitteldorf J. and Skulachev V.P. (2005) Programmed and altruistic
ageing. Nat. Rev. Genet. 6, 866-72.
[44] Mitteldorf J. (2006) How evolutionary thinking affects people's ideas about aging
interventions. Rejuvenation Res. 9, 346-50.
[45] De Magalhães J.P. and Toussaint, O. (2002) The evolution of mammalian aging. Exp.
Gerontol. 37, 769-75.
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
49
[46] Hayflick L. and Moorhead, P.S. (1961) The serial cultivation of human diploid cell
strains. Exp. Cell Res. 25, 585-621.
[47] Hayflick L. (1965) The limited in vitro lifetime of human diploid cell strains. Exp. Cell
Res. 37, 614-36.
[48] Martin G.M., Sprague C.A. and Epstein C.J. (1970) Replicative Life-Span of Cultivated
Human Cells. Effects of Donor's Age, Tissue, and Genotype. Lab. Invest. 23, 86-92.
[49] Rheinwald J.G. and Green H. (1975) Serial Cultivation of Strains of Human Epidermal
Keratinocytes: the Formation of Keratinizing Colonies from Single Cells. Cell 6, 33144.
[50] Bierman E.L. (1978) The effect of donor age on the in vitro life span of cultured human
arterial smooth-muscle cells. In Vitro 14, 951-5.
[51] Tassin J., Malaise E. and Courtois Y. (1979) Human lens cells have an in vitro
proliferative capacity inversely proportional to the donor age. Exp. Cell Res. 123, 38892.
[52] Röhme D. (1981) Evidence for a relationship between longevity of mammalian species
and life spans of normal fibroblasts in vitro and erythrocytes in vivo. Proc. Natl. Acad.
Sci. USA 78, 5009-13.
[53] Schneider E.L. and Mitsui Y. (1976) The relationship between in vitro cellular aging
and in vivo human age. Proc. Natl. Acad. Sci. USA 73, 3584-8.
[54] Wright W.E. and Hayflick L. (1975) Nuclear control of cellular ageing demonstrated by
hybridization of anucleate and whole cultured normal human fibroblasts. Exp. Cell. Res.
96, 113-21.
[55] Watson J.D. (1972) Origin of concatemeric T7 DNA. Nature New Biol. 239, 197-201.
[56] Olovnikov A.M. (1973) A theory of marginotomy: The incomplete copying of template
margin in enzyme synthesis of polynucleotides and biological significance of the
problem. J. Theor. Biol. 41, 181-90.
[57] Harley C.B., Futcher A.B. and Greider C.W. (1990) Telomeres shorten during ageing of
human fibroblasts. Nature 345, 458-60.
[58] Blackburn E.H. and Gall J.G. (1978) A tandemly repeated sequence at the termini of
the extrachromosomal ribosomal RNA genes in Tetrahymena. J Mol. Biol. 120, 33-53.
[59] Moyzis R.K., Buckingham J.M., Cram L.S., Dani M., Deaven L.L., Jones M.D., Meyne
J., Ratliff R.L. and Wu J.R. (1988) A highly conserved repetitive DNA sequence
(TTAGGG)n, present at the telomeres of human chromosomes. Proc. Natl. Acad. Sci.
USA. 85, 6622-6.
[60] Blackburn E.H. (1991) Structure and function of telomeres. Nature 350, 569-73.
[61] Greider C.W. and Blackburn E.H. (1985) Identification of a specific telomere terminal
transferase activity in Tetrahymena extracts. Cell 51, 405-13.
[62] Morin G.B. (1989) The human telomere terminal transferase enzyme is a
ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59, 521-9.
[63] van Steensel B. and de Lange T. (1997) Control of telomere length by the human
telomeric protein TRF1. Nature 385, 740-3.
[64] Yu G.L., Bradley J.D., Attardi L.D. and Blackburn E.H. (1990) In vivo alteration of
telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs.
Nature 344, 126-32.
50
Giacinto Libertini
[65] Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C., Morin G.B., Harley C.B.,
Shay J.W., Lichsteiner S. and Wright W.E. (1998) Extension of life-span by
introduction of telomerase into normal human cells. Science 279, 349-52.
[66] Counter C.M., Hahn W.C., Wei W., Caddle S.D., Beijersbergen R.L., Lansdorp P.M.,
Sedivy J.M. and Weinberg R.A. (1998) Dissociation among in vitro telomerase activity,
telomere maintenance, and cellular immortalization. Proc. Natl. Acad. Sci. USA 95,
14723-8.
[67] Vaziri H. (1998) Extension of life span in normal human cells by telomerase activation:
a revolution in cultural senescence. J. Anti-Aging Med. 1, 125-30.
[68] Vaziri H. and Benchimol S. (1998) Reconstitution of telomerase activity in normal cells
leads to elongation of telomeres and extended replicative life span. Cur. Biol. 8, 279-82.
[69] de Lange T. and Jacks T. (1999) For better or worse? Telomerase inhibition and cancer.
Cell 98, 273-5.
[70] Blackburn E.H. (2000) Telomere states and cell fates. Nature 408, 53-6.
[71] Pontèn J., Stein W.D. and Shall S. (1983) A Quantitative Analysis of the Aging of
Human Glial Cells in Culture. J. Cell Phys. 117, 342-52.
[72] Jones R.B., Whitney R.G. and Smith J.R. (1985) Intramitotic variation in proliferative
potential: stochastic events in cellular aging. Mech. Ageing Dev. 29, 143-9.
[73] Slijepcevic P., Hande M.P. (1999) Chinese hamster telomeres are comparable in size to
mouse telomeres. Cytogenet. Cell Genet. 85, 196-9.
[74] Fossel M.B. (2004) Cells, Aging and Human Disease, Oxford University Press, New
York (USA).
[75] Holt S.E., Shay J.W. and Wright W.E. (1996) Refining the telomere-telomerase
hypothesis of aging and cancer. Nature Biotechnol. 14, 836-9.
[76] Prowse K.R. and Greider C.W. (1995) Developmental and tissue-specific regulation of
mouse telomerase and telomere length. Proc Natl Acad Sci USA 92, 4818-22.
[77] Herrera E., Samper E., Martín-Caballero J., Flores J.M.., Lee H.W. and Blasco M.A.
(1999) Disease states associated with telomerase deficiency appear earlier in mice with
short telomeres. EMBO J. 18, 2950-60.
[78] Blasco M.A., Lee H.W., Hande M.P., Samper E., Lansdorp P.M., DePinho R.A. and
Greider C.W. (1997) Telomere shortening and tumor formation by mouse cells lacking
telomerase RNA. Cell 91, 25-34.
[79] Lee H.W., Blasco M.A., Gottlieb G.J., Horner J.W. 2nd, Greider C.W. and DePinho
R.A. (1998) Essential role of mouse telomerase in highly proliferative organs. Nature
392, 569-74.
[80] Kerr J.F.R., Wyllie A.H. and Currie A.R. (1972) Apoptosis: a basic biological
phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 23957.
[81] Laun P., Bruschi C.V., Dickinson J.R., Rinnerthaler M., Heeren G., Schwimbersky R.,
Rid R. and Breitenbach M. (2007) Yeast mother cell-specific ageing, genetic
(in)stability, and the somatic mutation theory of ageing. Nucleic Acids Res. 35, 751426.
[82] Kaeberlein M., Burtner C.R. and Kennedy B.K. (2007) Recent Developments in Yeast
Aging PLoS Genetics 3(5): e84.
[83] Wyllie A.H., Kerr J.F.R. and Currie A.R. (1980) Cell Death: The Significance of
Apoptosis. Int. Rev. Cytol. 68, 251-306.
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
51
[84] Lynch M.P., Nawaz S. and Gerschenson L.E. (1986) Evidence for soluble factors
regulating cell death and cell proliferation in primary cultures of rabbit endometrial
cells grown on collagen. Proc. Natl. Acad. Sci. USA 83, 4784-8.
[85] Medh R.D. and Thompson E.B. (2000) Hormonal regulation of physiological cell
turnover and apoptosis. Cell Tissue Res. 301, 101-24.
[86] Harada K., Iwata M., Kono N., Koda W., Shimonishi T. and Nakanuma Y. (2000)
Distribution of apoptotic cells and expression of apoptosis-related proteins along the
intrahepatic biliary tree in normal and non-biliary diseased liver. Histopathology 37,
347-54.
[87] Cardani R. and Zavanella T. (2000) Age-related Cell Proliferation and Apoptosis in the
Kidney of Male Fischer 344 Rats with Observations on a Spontaneous Tubular Cell
Adenoma. Toxicol. Pathol. 28, 802-6.
[88] Finegood D.T., Scaglia L. and Bonner-Weir S. (1995) Dynamics of beta-cell mass in
the growing rat pancreas. Estimation with a simple mathematical model. Diabetes 44,
249-56.
[89] Benedetti A., Jezequel A.M. and Orlandi F. (1988) A quantitative evaluation of
apoptotic bodies in rat liver. Liver 8, 172-7.
[90] Dremier S., Golstein J., Mosselmans R., Dumont J.E., Galand P. and Robaye B. (1994)
Apoptosis in dog thyroid cells. Biochem. Biophys. Res. Comm. 200, 52-8.
[91] Sutherland L.M., Edwards Y.S. and Murray A.W. (2001) Alveolar type II cell
apoptosis. Comp. Biochem. Physiol. 129A, 267-85.
[92] Héraud F., Héraud A. and Harmand M.F. (2000) Apoptosis in normal and osteoarthritic
human articular cartilage. Ann. Rheum. Dis. 59, 959-65.
[93] Xia S.J., Xu C.X., Tang X.D., Wang W.Z. and Du D.L. (2001) Apoptosis and hormonal
milieu in ductal system of normal prostate and benign prostatic hyperplasia. Asian J.
Androl. 3, 131-4.
[94] Prins J.B. and O’Rahilly S. (1997) Regulation of adipose cell number in man. Clin. Sci.
(Lond.) 92, 3-11.
[95] Spelsberg T.C., Subramaniam M., Riggs B.L. and Khosla S. (1999) The Actions and
Interactions of Sex Steroids and Growth Factors/Cytokines on the Skeleton. Mol.
Endocrinol. 13, 819-28.
[96] Migheli A., Mongini T., Doriguzzi C., Chiadò-Piat L., Piva R., Ugo I. and Palmucci L.
(1997) Muscle apoptosis in humans occurs in normal and denervated muscle, but not in
myotonic dystrophy, dystrophinopathies or inflammatory disease. Neurogenetics 1, 817.
[97] Pollack M. and Leeuwenburgh C. (2001) Apoptosis and aging: role of the
mitochondria. J. Gerontol. A Biol. Sci. Med. Sci. 56, B475-82.
[98] Reed J.C. (1999) Dysregulation of Apoptosis in Cancer. J. Clin. Oncol. 17, 2941-53.
[99] Andreeff M., Goodrich D.W. and Pardee A B. (2000) Cell proliferation, differentiation,
and apoptosis. In: Holland-Frei, Cancer Medicine, 5th ed., B. C. Decker Inc. ed.,
Hamilton, Ontario (Canada) and London (UK).
[100] Marciniak R. and Guarente L. (2001) Human genetics. Testing telomerase. Nature 413,
370-2.
[101] Anversa P. and Nadal-Ginard B. (2002) Myocyte renewal and ventricular remodelling.
Nature 415, 240-3.
52
Giacinto Libertini
[102] Schultz E. and Lipton B.H. (1982) Skeletal muscle satellite cells: changes in
proliferation potential as a function of age. Mech. Age. Dev. 20, 377-83.
[103] Carlson B.M. and Faulkner J.A. (1989) Muscle transplantation between young and old
rats: age of host determines recovery. Am. J. Physiol. 256, C1262-6.
[104] Adams V., Gielen S. Hambrecht R. and Schuler G. (2001) Apoptosis in skeletal muscle.
Front. Biosci. 6, D1-D11.
[105] Horner P.J. and Gage F.H. (2000) Regenerating the damaged central nervous system.
Nature 407, 963-70.
[106] DePinho R.A. (2000) The age of cancer. Nature 408, 248-54.
[107] Dokal I. (2000) Dyskeratosis congenita in all its forms. Br. J. Haematol. 110, 768-79.
[108] Martin G.M. and Oshima J. (2000) Lessons from human progeroid syndromes. Nature
408, 263-6.
[109] Vulliamy T., Marrone A., Goldman F., Dearlove A., Bessler M., Mason P.J. and Dokal
I. (2001) The RNA component of telomerase is mutated in autosomal dominant
dyskeratosis congenita. Nature 413, 432-5.
[110] Mitchell J.R., Wood E. and Collins K. (1999) A telomerase component is defective in
the human disease dyskeratosis congenita. Nature 402, 551-5.
[111] Artandi S.E. (2002) Telomere shortening and cell fates in mouse models of neoplasia.
Trends Mol. Med. 8, 44-7.
[112] Artandi S.E., Chang S., Lee S.L., Alson S., Gottlieb G.J., Chin L. and DePinho R.A.
(2000) Telomere dysfunction promotes non-reciprocal translocations and epithelial
cancers in mice. Nature 406, 641-5.
[113] Yu, C.E., Oshima J. Fu Y.H., Wijsman E.M., Hisama F., Alisch R. Matthews S.,
Nakura J., Miki T., Ouais S., Martin G.M., Mulligan J. and Schellenberg G.D. (1996)
Positional Cloning of the Werner's Syndrome Gene. Science 272, 258-62.
[114] Fukuchi K., Martin G.M. and Monnat R.J.Jr. (1989) Mutator phenotype of Werner
syndrome is characterized by extensive deletions. Proc. Natl. Acad. Sci. USA 86, 58937. [Published erratum appears in Proc. Natl. Acad. Sci. USA 86, 7994 (1989)].
[115] Goto M., Miller R.W., Ishikawa, Y. and Sugano H. (1996) Excess of Rare Cancers in
Werner Syndrome (Adult Progeria). Cancer Epidemiol. Biomarkers Prev. 5, 239-46.
[116] Gimbrone M.A.Jr. (1999) Endothelial Dysfunction, Hemodynamic Forces, and
Atherosclerosis. Thromb. Haemost. 82, 722-6.
[117] Hill J.M., Zalos G., Halcox J.P.J., Schenke W.H., Waclawiw M.A., Quyyumi A.A. and
Finkel T. (2003) Circulating endothelial progenitor cells, vascular function, and
cardiovascular risk. N. Engl. J. Med. 348, 593-600.
[118] Bonner-Weir S. (2000) Islet growth and development in the adult. J. Mol. Endocrinol.
24, 297-302.
[119] Cerasi E., Kaiser N. and Leibowitz G. (2000) [Type 2 diabetes and beta cell apoptosis]
[Article in French]. Diabetes Metab. 26, 13-6.
[120] Masoro E.J. (1998) Physiology of aging. In Brocklehurst’s Textbook of Geriatric
Medicine and Gerontology, Tallis R.C., Fillit H.M. and Brocklehurst J.C. (Eds.), 5th ed.,
Churchill Livingstone, New York (USA).
[121] Davies I. (1998) Cellular Mechanisms of Aging. In: Tallis et al. (Eds.), Brocklehurst’s
etc.
[122] Tyner S.D., Venkatachalam S., Choi J., Jones S., Ghebranious N., Igelmann H., Lu X.,
Soron G., Cooper B., Brayton C., Hee Park S., Thompson T., Karsenty G., Bradley A.
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
53
and Donehower L.A. (2002) p53 mutant mice that display early ageing-associated
phenotypes. Nature 415, 45-53.
[123] Werner N., Kosiol S., Schiegl T., Ahlers P., Walenta K., Link A., Böhm M. and
Nickenig G. (2005) Circulating endothelial progenitor cells and cardiovascular
outcomes. N. Engl. J. Med. 353, 999-1007.
[124] Tallis R.C., Fillit H.M. and Brocklehurst J.C. (Eds.) (1998) Brocklehurst’s Textbook of
Geriatric Medicine and Gerontology, 5th ed., Churchill Livingstone, New York (USA).
[125] Davidson M.H. (2007) Overview of prevention and treatment of atherosclerosis with
lipid-altering therapy for pharmacy directors. Am. J. Manag. Care 13, S260-9.
[126] Weir M.R. (2007) Effects of renin-angiotensin system inhibition on end-organ
protection: can we do better? Clin. Ther. 29, 1803-24.
[127] Griffiths C.E.M. (1998) Aging of the Skin. In: Tallis et al. (Eds.), Brocklehurst’s etc.
[128] Brodie S.E. (1998) Aging and Disorders of the Eye. In: Tallis et al. (Eds.),
Brocklehurst’s etc.
[129] Devlin H. and Ferguson M.W.J. (1998) Aging and the Orofacial Tissues. In: Tallis et al.
(Eds.), Brocklehurst’s etc.
[130] Reinus J.F. and Brandt L.J. (1998) The Upper Gastrointestinal Tract. In: Tallis et al.
(Eds.), Brocklehurst’s etc.
[131] Bird T., Hall M.R.P. and Schade R.O.K. (1977) Gastric Histology and Its Relation to
Anaemia in the Elderly. Gerontology 23, 309-21.
[132] Tepper R.E. and Katz S. (1998) Overview: Geriatric Gastroenterology. In: Tallis et al.
(Eds.), Brocklehurst’s etc.
[133] Webster S.G.P. (1978) The gastrointestinal system – c. The pancreas and the small
bowel. In: Textbook of Geriatric Medicine and Gerontology (Brocklehurst J.C., ed.), 2nd
ed., Churchill Livingstone, New York (USA).
[134] Barker N., van Es J.H., Kuipers J., Kujala P., van den Born M., Cozijnsen M.,
Haegebarth A., Korving J., Begthel H., Peters P.J. and Clevers H. (2007) Identification
of stem cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003-7
[135] Marchesini G., Bua V., Brunori A., Bianchi G., Pisi P., Fabbri A., Zoli M. and Pisi E.
(1988) Galactose Elimination Capacity and Liver Volume in Aging Man. Hepatology 8,
1079-83.
[136] Wynne H.A., Cope L.H., Mutch E., Rawlins M.D., Woodhouse K.W. and James O.F.
(1989) The Effect of Age upon Liver Volume and Apparent Liver Blood Flow in
Healthy Man. Hepatology 9, 297-301.
[137] James O.F.W. (1998) The Liver. In: Tallis et al. (Eds.), Brocklehurst’s etc.
[138] Harris M.I., Hadden W.C., Knowler W.C., Bennett P.H. (1987) Prevalence of diabetes
and impaired glucose tolerance and plasma glucose levels in U.S. population aged 2074 yr. Diabetes 36, 523-34.
[139] McCall K.L., Craddock D. and Edwards K. (2006) Effect of angiotensin-converting
enzyme inhibitors and angiotensin II type 1 receptor blockers on the rate of new-onset
diabetes mellitus: a review and pooled analysis. Pharmacotherapy 26, 1297-306.
[140] Ostergren J. (2007) Renin-angiotensin-system blockade in the prevention of diabetes.
Diabetes Res. Clin. Pract. 78, S13-21.
[141] Olivetti G., Melissari M., Capasso J. M. and Anversa P. (1991) Cardiomyopathy of the
Aging Human Heart. Myocyte Loss and Reactive Cellular Hypertrophy. Circ. Res. 68,
1560-8.
54
Giacinto Libertini
[142] Aronow W.S. (1998) Effects of Aging on the Heart. In: Tallis et al. (Eds.),
Brocklehurst’s etc.
[143] Caird F.I. and Dall J.L.C. (1978) The cardiovascular system. In: Textbook of Geriatric
Medicine and Gerontology (Brocklehurst J.C., ed.), 2nd ed., Churchill Livingstone, New
York (USA).
[144] Jibrini M.B., Molnar J. and Arora R.R. (2008) Prevention of atrial fibrillation by way of
abrogation of the renin-angiotensin system: a systematic review and meta-analysis. Am.
J. Ther. 15, 36-43.
[145] Fauchier L., Pierre B., de Labriolle A., Grimard C., Zannad N. and Babuty D. (2008)
Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of
randomized controlled trials. J. Am. Coll. Cardiol. 51, 828-35.
[146] Enright P.L., Kronmal R.A., Higgins M., Schenker M. and Haponik E.F. (1993)
Spirometry Reference Values for Women and Men 65 to 85 Years of Age.
Cardiovascular Health Study. Am. Rev. Respir. Dis. 147, 125-33.
[147] Connolly M.J. (1998) Age-Related Changes in the Respiratory System. In: Tallis et al.
(Eds.), Brocklehurst’s etc.
[148] Alexeeff S.E., Litonjua A.A., Sparrow D., Vokonas P.S. and Schwartz J. (2007) Statin
use reduces decline in lung function. Amer. J. Respir. Crit. Care Medic. 176, 742-7.
[149] Jassal V., Fillit H. and Oreopoulos D.G. (1998) Aging of the Urinary Tract. In: Tallis et
al. (Eds.), Brocklehurst’s etc.
[150] Weir M.R. (2007) Microalbuminuria and cardiovascular disease. Clin. J. Am. Soc.
Nephrol. 2, 581-90.
[151] Grimby G., Danneskiold-Samsøe B., Hvid K. and Saltin B. (1982) Morphology and
enzymatic capacity in arm and leg muscles in 78-81 year old men and women. Acta
Physiol. Scand. 115, 125-34.
[152] Lexell J., Taylor C.C. and Sjöström M. (1988) What is the cause of the ageing atrophy?
Total number, size and proportion of different fiber types studied in whole vastus
lateralis muscle from 15- to 83-year-old men. J. Neurol. Sci. 84, 275-94.
[153] Cumming W.J.F. (1998) Aging and Neuromuscular Disease In: Tallis et al. (Eds.),
Brocklehurst’s etc.
[154] Dieppe P. and Tobias J. (1998) Bone and Joint Aging. In: Tallis et al. (Eds.),
Brocklehurst’s etc.
[155] Francis R.M. (1998) Metabolic Bone Disease. In: Tallis et al. (Eds.), Brocklehurst’s etc.
[156] Gilleece M.H. and Dexter T.M. (1998) Aging and the Blood. In: Tallis et al. (Eds.),
Brocklehurst’s etc.
[157] MacGregor R.R. and Shalit M. (1990) Neutrophil Function in Healthy Elderly Subjects.
J. Gerontol. 45, M55-60.
[158] Gravenstein S., Fillit H. and Ershler W.B. (1998) Clinical Immunology of Aging. In:
Tallis et al. (Eds.), Brocklehurst’s etc.
[159] Geiger H. and Van Zant G. (2002) The aging of lympho-hematopoietic stem cells. Nat.
Immunol. 3, 329-33.
[160] Mann D.M.A. (1988) Neurobiology of Aging. In: Tallis et al. (Eds.), Brocklehurst’s etc.
[161] Klein B.E., Klein R., Lee K.E. and Grady L.M. (2006) Statin use and incident nuclear
cataract. JAMA 295, 2752-8.
[162] Fine S.L., Berger J.W., Maguire M.G. and Ho A.C. (2000) Age-related macular
degeneration. N. Engl. J. Med. 342, 483-92.
The Role of Telomere-Telomerase System in Age-Related Fitness Decline…
55
[163] Berger J.M., Fine S.L. and Maguire M.G. (1999) Age-related macular degeneration,
Mosby (USA).
[164] Klein R., Deng Y., Klein B.E., Hyman L., Seddon J., Frank R.N., Wallace R.B.,
Hendrix S.L., Kuppermann B.D., Langer R.D., Kuller L., Brunner R., Johnson K.C.,
Thomas A.M. and Haan M. (2007) Cardiovascular disease, its risk factors and
treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam
ancillary study. Am. J. Ophthalmol. 143, 473-83.
[165] Gorelick P.B. (2004) Risk Factors for Vascular Dementia and Alzheimer Disease.
Stroke 35, 2620-2.
[166] Vogel T., Benetos A., Verreault R., Kaltenbach G., Kiesmann M. and Berthel M.
(2006) [Risk factors for Alzheimer: towards prevention?] [Article in French]. Presse
Med. 35, 1309-16.
[167] Ellul J., Archer N., Foy C.M., Poppe M., Boothby H., Nicholas H., Brown R.G. and
Lovestone S. (2007) The effects of commonly prescribed drugs in patients with
Alzheimer’s disease on the rate of deterioration. J. Neurol. Neurosurg. Psychiatry 78,
233-9.
[168] Campisi J. (1997) The biology of replicative senescence. Eur. J. Cancer 33, 703-9.
[169] Wright W.E. and Shay J.W. (2005) Telomere biology in aging and cancer. J. Am.
Geriatr. Soc. 53, S292-4.
[170] Campisi J. (2000) Cancer, aging and cellular senescence. In Vivo 14, 183-8.
[171] Klapper W., Heidorn H., Kühne K., Parwaresch R., and Krupp G. (1998) Telomerase in
'immortal fish'. FEBS Letters 434, 409-12.
[172] Klapper W., Kühne K., Singh K.K., Heidorn K., Parwaresch R. and Krupp G. (1998).
Longevity of lobsters is linked to ubiquitous telomerase expression. FEBS Letters 439,
143-6.
[173] Rosen P. (1985) Aging of the immune system. Med Hypotheses 18, 157-61.
[174] Jazwinski S.M. (1993) The genetics of aging in the yeast Saccharomyces cerevisiae.
Genetica 91, 35-51.
[175] Lesur I. & Campbell J.L. (2004) The transcriptome of prematurely aging yeast cells is
similar to that of telomerase-deficient cells. MBC Online 15, 1297-312.
[176] Laun P., Pichova A., Madeo F., Fuchs J., Ellinger A., Kohlwein S., Dawes I., Fröhlich
K.U. & Breitenbach M. (2001) Aged mother cells of Saccharomyces cerevisiae show
markers of oxidative stress and apoptosis. Mol. Microbiol. 39, 1166-73.
[177] Skulachev V.P. (2002) Programmed death in yeast as adaptation? FEBS Lett. 528, 23-6.
[178] Skulachev V.P. (2003) Aging and the programmed death phenomena. In: Topics in
Current Genetics, Vol. 3, T. Nyström, H.D. Osiewacz (Eds..) Model Systems in Aging,
Springer-Verlag, Berlin Heidelberg.
[179] Herker E., Jungwirth H., Lehmann K.A., Maldener C., Fröhlich K.-U., Wissing S.,
Büttner S., Fehr M., Sigrist S. and Madeo F. (2004) Chronological aging leads to
apoptosis in yeast. J. Cell Biol., 164, 501-7.
[180] Skulachev V.P. & Longo V.D. (2005) Aging as a mitochondria-mediated atavistic
program: can aging be switched off? Ann. N. Y. Acad. Sci. 1057, 145-64.
[181] Finch C.E. (1990) Longevity, Senescence, and the Genome, University of Chicago
Press, Chicago.
[182] Finch C.E. and Hayflick L. (Eds..) (1977) Handbook of the biology of aging, Van
Nostrand Reinhold Company, New York.
56
Giacinto Libertini
[183] Van Voorhies W.A., Fuchs J. and Thomas S. (2005) The longevity of Caenorhabditis
elegans in soil, Biol. Letters 1, 247-9.
[184] Johnson T.E. (1987) Aging can be genetically dissected into component processes using
long-lived lines of Caenorhabditis elegans. Proc. Natl. Acad. Sci. 84, 3777-81.
[185] Arking R. (1998) Biology of aging. 2nd ed., Sinauer Associates, Sunderland, MA
(USA).
[186] Johnson T.E. (2007) Caenorhabditis elegans 2007: the premier model for the study of
aging. Exp. Gerontol. 43, 1-4.
[187] Petrascheck M., Ye X. and Buck L.B. (2007) An antidepressant that extends lifespan in
adult Caenorhabditis elegans. Nature 450, 553-6.
[188] Kennedy B.K. (2008) The genetics of ageing: insight from genome-wide approaches in
invertebrate model organisms. J. Intern. Med. 263, 142-52.
[189] Finch C.E. and Austad S.N. (2001) History and prospects: symposium on organisms
with slow aging, Exp. Gerontol. 36, 593-7.
[190] Vaupel J.W., Baudisch A., Dölling M., Roach D.A. and Gampe J. (2004) The case for
negative senescence. Theor. Popul. Biol. 65, 339-51.
[191] Cailliet G.M., Andrews A.H., Burton E.J., Watters D.L., Kline D.E. and Ferry-Graham
L.A. (2001) Age determination and validation studies of marine fishes: do deepdwellers live longer? Exp. Gerontol. 36, 739-64.
[192] De Bruin J.P., Gosden R.G., Finch C.E., Leaman B.M (2004) Ovarian aging in two
species of long-lived rockfish, Sebastes aleutianus and S. alutus. Biol Reprod. 71, 103642.
[193] De Grey A.D. (2007) Calorie restriction, post-reproductive life span, and programmed
aging: a plea for rigor. Ann. N. Y. Acad. Sci. 1119, 293-305.
[194] Martuscelli S. (1979) [The population of the South of Italy in the statistic of King
Murat] [Book in Italian]. Guida Editori, Naples (Italy).
[195] Comfort A. (1979). The Biology of Senescence. Livingstone, London (UK).
[196] Meyer F. and Finer M. (2001) Gene therapy: progress and challenges. Cell. Mol. Biol.
(Noysy-le-grand) 47, 1277-94.
[197] Fischer A. (2001) Gene therapy: some results, many problems to solve. Cell. Mol. Biol.
(Noisy-le-grand) 47, 1269-75.
[198] Flotte T.R. (2007) Gene therapy: the first two decades and the current state-of-the-art. J.
Cell. Physiol. 213, 301-5.
[199] Horan M.A. (1998) Presentation of Disease in Old Age. In: Tallis et al. (Eds.),
Brocklehurst’s etc.
[200] De Grey A. (2005) The SENS Challenge: $20,000 Says the Foreseeable Defeat of
Aging Is Not Laughable. Rejuvenation Res. 4, 207-10.
[201] Kuhn T.S. (1962) The Structure of Scientific Revolutions, The University of Chicago
Press, Chicago.
Reviewed by:
Prof. Vladimir P. Skulachev,
Sc.D., Head of Department,
Academician of Russian Academy of Sciences